
TRANS = {
    "EN": {
        "title": "Prognostic Research Sample Size Tool",
        "sidebar_title": "Configuration",
        "language": "Language / Ng√¥n ng·ªØ",
        "mode": "Method Selection",
        "mode_riley": "Method C5: Riley et al. (Analytical)",
        "mode_bayes": "Method C6: Bayesian Assurance (Simulation)",
        "mode_single": "Single Scenario",
        "mode_batch": "Sensitivity Analysis (Ranges)",
        "method1_tab": "Method C5 (Riley)",
        "method2_tab": "Method C6 (Bayesian)",
        "nav_title": "Navigation",
        "nav_intro": "Introduction & Formulas",
        "nav_calc": "Sample Size Calculator",
        "intro_heading": "Welcome",
        "intro_text": "This tool helps researchers calculate the minimum sample size required for developing a clinical prediction model with a binary outcome.",
        "formula_heading": "Mathematical Framework (Method C5)",
        "formula_intro": "Method C5 uses the closed-form solutions provided by Riley et al., while Method C6 uses Bayesian MCMC simulation.",
        "sens_guide_title": "üí° How to use Sensitivity Analysis (Batch Mode)",
        "sens_guide_text": """
        - **Ranges**: Enter `min-max` (e.g., `0.05-0.10`). The app will generate steps automatically.
        - **Specific Values**: Enter comma-separated lists (e.g., `0.05, 0.10, 0.15`).
        """,
        "detail_view": "View Detailed Calculation for Scenario",
        "footer_refs": "References: Riley et al. (2018, 2020), BayesAssurance.",
        "calc_btn": "Calculate",
        "results": "Results",
        "sanity": "Sanity Check (EPV Rules)",
        "download_csv": "Download CSV",
        "download_report": "Download Full Report",
        "error_p": "Prevalence must be between 0 and 1.",
        "error_auc": "AUC must be between 0.5 and 1.",
        "error_parse": "Could not parse input.",
        
        # Riley specific
        "riley_inputs": "Input Parameters (Riley)",
        "prevalence": "Outcome Prevalence (Event Rate)",
        "prevalence_help": "Proportion of participants with the event (0 < p < 1).",
        "parameters": "Number of Predictor Parameters (df)",
        "parameters_help": "Total degrees of freedom (excluding intercept).",
        "shrinkage": "Target Global Shrinkage (S)",
        "shrinkage_help": "Desired shrinkage factor (default 0.9).",
        "perf_measure": "Anticipated Performance",
        "perf_auc": "AUC (C-statistic)",
        "perf_r2": "Cox-Snell R-squared",
        "perf_cons": "Conservative (15% of Max R2)",
        
        # Bayesian specific 
        "perf_cons_help": "Conservative (15% of Max R2)",
        "perf_auc_help": "Anticipated AUC (C-statistic)",
        "perf_r2_help": "Anticipated Cox-Snell R-squared",
        "perf_cons_help": "Conservative (15% of Max R2)",
        # Bayesian specific
        "bayes_inputs": "Simulation Settings (Bayesian Assurance)",
        "dgm_settings": "Data Generating Mechanism",
        "sim_settings": "Simulation & MCMC",
        "eval_settings": "Evaluation Criteria",
        "n_candidates": "Candidate Sample Sizes (comma separated)",
        "n_candidates_help": "List of N values to test, e.g., 500, 1000, 1500.",
        "correlation": "Predictor Correlation (rho)",
        "n_sims": "Number of Simulations per N",
        "assurance_threshold": "Assurance Threshold (Target Probability)",
        "run_simulation": "Run Bayesian Simulation",
        "simulation_running": "Running Simulations... This may take a while.",
        "assurance_result": "Assurance Analysis",
        
        # Method 6 (Dev Sim)
        "mode_dev_sim": "Method 6: Development Simulation (Freq)",
        "method6_tab": "Method 6 (Simulation)",
        "dev_sim_intro": "Simulation-based sample size for model development (frequentist approach similar to `samplesizedev`).",
        "dev_mode_simple": "Mode A: Simple (AUC-driven)",
        "dev_mode_custom": "Mode B: Custom DGM",
        "target_auc": "Target Mean AUC (C-statistic)",
        "target_auc_help": "Algorithm will find Beta coefficients to achieve this AUC.",
        "criteria_settings": "Performance Criteria (Pass/Fail)",
        "crit_slope_mean": "Mean Calibration Slope >= 0.9",
        "crit_slope_ci": "Pr(0.9 <= Slope <= 1.1) >= 80%",
        "crit_auc": "Mean AUC >= Target",
        "audit_trail": "RNG Audit Trail (JSON)",
        "future_methods": "Coming in future versions...",
        
        # Quick Methods
        "method_quick_tab": "A. Quick / Basic",
        "quick_mode_epv": "A1: EPV / EPP Rule (Heuristic)",
        "quick_mode_risk": "A2: Baseline Risk Precision (CI Width)",
        "target_epv": "Target Events Per Parameter (EPP)",
        "target_epv_help": "Common heuristic values are 10, 15, 20. EPP is preferred over EPV.",
        "epv_warning_title": "‚ö†Ô∏è Important Warning",
        "epv_warning_text": "EPV/EPP is a rough heuristic. It does not guarantee calibration, discrimination, or prevent optimism. It is sensitive to variable selection and non-linear terms.",
        "ci_level": "Confidence Level",
        "ci_half_width": "Target Half-Width (Margin of Error)",
        "ci_method": "CI Method",
        "ci_method_wilson": "Wilson Score (Recommended)",
        "ci_method_wald": "Wald (Simple)",
        "ci_method_cp": "Clopper-Pearson (Conservative)",
        "risk_help": "Calculates N to estimate the event rate p with a specific precision. Does not ensure prediction model performance.",
        
        # Power Methods (B)
        "title_b3": "B3: Logistic Power (Hsieh)",
        "title_b4": "B4: Cox Power (Schoenfeld)",
        "interpretation": "Interpretation",
        
        # UI Basics
        "d8_assumptions": "**Assumptions**: Uses Hanley & McNeil (1982) variance approximation. Symmetric Normal assumption for AUC. Numerical optimization to find N.",
        "d8_mode_n_to_width": "Compute CI width from N",
        "d8_mode_width_to_n": "Compute required N from CI width",
        "d8_opt_settings": "Advanced Optimizer Settings",
        "d8_practical_rounding": "Show Practical Integer Rounding",
        "d8_n_input": "Sample Size (N)",
        "d8_width_input": "CI Width (Total)",
        "d8_opt_bound": "Search Upper Limit",
        "d8_opt_tol": "Tolerance",
        
        # Validations (D)
        "title_d8": "D8: AUC Precision (Hanley-McNeil)",
        "d8_desc": "Calculate sample size for estimating AUC with desired precision (CI width).",
        "auc_expected": "Expected AUC (C-statistic)",
        "formulas_header": "üìö Formulas & Technical Details",
        "d8_assumptions": "**Assumptions**: Uses Hanley & McNeil (1982) variance approximation. Symmetric Normal assumption for AUC.",
        "d8_mode_n_to_width": "Calculate CI Width from N",
        "d8_mode_width_to_n": "Calculate N from CI Width",
        "d8_opt_settings": "Advanced Optimizer Settings",
        "d8_practical_rounding": "Show Practical Rounding",
        "d8_n_input": "Sample Size (N)",
        "d8_width_input": "CI Width (Total)",
        "d8_opt_bound": "Search Upper Limit",
        "d8_opt_tol": "Tolerance",
        
        # D9
        "title_d9": "D9: External Validation (Tailored)",
        "common_inputs": "Common Parameters",
        
        # UI Basics
        "search_placeholder": "Search methods...",
        "settings": "Settings",
        
        # Footer
        "footer_copyright": "¬© 2026 Prognostic Research Sample Size Tool. For academic/research only.",
        "footer_author": "Author & Maintenance: Minh Nguyen (minhnt@ump.edu.vn)",
        "footer_disclaimer": "Disclaimer: No clinical warranty; users are responsible for validation and interpretation.",

        "intro_complete_md": """
### Welcome

This app helps clinicians and researchers plan minimum sample size for prognostic research, including:
* Prognostic factor studies (power to detect associations),
* Clinical prediction model development (risk prediction), and
* Model validation / updating (external validation, recalibration).

It is designed for binary outcomes (e.g., event vs no event) and, for some modules, time-to-event outcomes (Cox PH).

Source code (download): [https://gitlab.com/minhthiennguyen/pmsample/](https://gitlab.com/minhthiennguyen/pmsample/)
or [https://github.com/nguyenminh2301/pmsample.git](https://github.com/nguyenminh2301/pmsample.git)    

### Getting started (for new users)

#### 1. Clarify your study goal
* Are you testing a single prognostic factor (association)?
* Are you building a prediction model?
* Are you validating an existing model in a new population?

#### 2. Estimate the event rate $p$ (or event fraction for survival)
* Prefer local hospital data (best).
* If uncertain, enter a range and run a sensitivity analysis.

#### 3. Count model complexity correctly (parameters / df)
Use parameters (degrees of freedom), not just "number of variables."
* Binary predictor: 1 df
* Categorical with $L$ levels: $L-1$ df
* Spline (RCS with $K$ knots): $K-1$ df
* Interaction: $df(A \\times B) = df(A) \\cdot df(B)$

#### 4. Choose a method from the catalog below
* Use **"Quick tools"** for rough planning only.
* Use **Riley / simulation / assurance** when you are developing a prediction model.

---

### When to use this app (and when not to)

**Use this app when you are:**
* Planning retrospective or prospective cohort studies in prognosis/prediction
* Developing or validating risk prediction models
* Estimating sample size for precision (CI width) of prevalence or AUC
* Designing external validation with calibration and discrimination targets

**Do NOT use this app as the primary tool when you are:**
* Designing randomized controlled trials (use RCT-specific power/sample size methods)
* Planning diagnostic accuracy studies for sensitivity/specificity without prediction modeling
* Expecting a single "correct" number: sample size planning requires assumptions and should include sensitivity analyses

---

### Available Methods (Overview)

#### A. Quick / Basic (fast, approximate)

**A1 ‚Äî Rules of Thumb (EPV/EPP) (heuristic)**
* **Use when:** you need a quick sanity check on whether events are "roughly sufficient" for a planned model size.
* **Do not use when:** model includes splines/interactions/variable selection, or event rate is low‚ÄîEPV/EPP does not guarantee good calibration or low optimism.
* **Key inputs:** event rate $p$, number of parameters $P$ (df), target EPP (e.g., 10/15/20)
* **Core output:** required events $E=t \\cdot P$, required sample size $N=\\lceil E/p \\rceil$
* **Strengths:** extremely simple; good for early feasibility
* **Weaknesses:** can be misleading; not performance-based

**A2 ‚Äî Baseline Risk Precision (CI width for prevalence)**
* **Use when:** your goal is to estimate the event rate $p$ with a desired CI half-width (e.g., ¬±2%).
* **Do not use when:** you want prediction model performance guarantees (AUC/calibration slope).
* **Key inputs:** expected $p$, CI method (Wilson recommended), confidence level, target half-width $d$
* **Core output:** minimum $N$ such that CI half-width $\\le d$
* **Strengths:** direct precision target; transparent assumptions
* **Weaknesses:** about prevalence only, not model performance

#### B. Prognostic factor (power) (association-focused, not prediction model sizing)

**B3 ‚Äî Logistic OR Power (Hsieh)**
* **Use when:** you want power to detect a target odds ratio (OR) for a prognostic factor in logistic regression.
* **Do not use when:** your primary goal is prediction model development (calibration/discrimination), not hypothesis testing.
* **Key inputs:** baseline risk $p_0$, target OR, alpha, power, exposure prevalence (binary) or SD (continuous), optional $R^2$ with covariates
* **Core output:** required $N$ (and implied events) to detect the OR
* **Strengths:** classic power framework for association
* **Weaknesses:** does not address prediction model performance; sensitive to input assumptions

**B4 ‚Äî Cox HR Power (Schoenfeld)**
* **Use when:** time-to-event outcome; you want power to detect a hazard ratio (HR) under Cox PH.
* **Do not use when:** PH assumption likely violated, or event fraction is highly uncertain and cannot be reasonably estimated.
* **Key inputs:** HR, alpha, power, allocation proportion (binary) or SD (continuous), expected event fraction during follow-up
* **Core output:** required number of events; convert to $N$ using event fraction
* **Strengths:** widely accepted; event-based planning is intuitive
* **Weaknesses:** depends strongly on event fraction and follow-up/censoring assumptions

#### C. Prediction model development (recommended for risk model building)

**C5 ‚Äî Riley et al. (Analytical; pmsampsize-like)**
* **Use when:** developing a multivariable prediction model; you want to control overfitting and ensure adequate precision.
* **Do not use when:** you cannot provide reasonable assumptions for prevalence and anticipated model performance (AUC or $R^2$); in that case, use sensitivity analysis or simulation.
* **Key inputs:** event rate $p$, parameters $P$ (df), target shrinkage (e.g., 0.90), anticipated model performance (AUC or Cox‚ÄìSnell $R^2$)
* **Core output:** minimum $N$ meeting multiple criteria (overfitting control + precision)
* **Strengths:** principled, performance-aware, widely cited
* **Weaknesses:** depends on performance assumptions; requires careful df counting

**C6 ‚Äî Development Simulation (Frequentist; samplesizedev/custom DGM)**
* **Use when:** you prefer "simulate what you will do," especially with nonlinearity/interactions and custom data structures.
* **Do not use when:** you cannot specify a plausible data-generating mechanism (DGM) or you need results instantly (compute-intensive).
* **Key inputs:** candidate $N$ grid, DGM assumptions (predictor distributions/correlations/effects), performance targets (e.g., calibration slope range, AUC threshold), simulation replicates, seed
* **Core output:** smallest $N$ achieving targets with acceptable probability/precision
* **Strengths:** flexible; aligns with complex modeling
* **Weaknesses:** assumptions-heavy; computational cost

**C7 ‚Äî Bayesian Assurance (MCMC)**
* **Use when:** the final model will be estimated with Bayesian MCMC, and you want sample size based on assurance (probability of meeting posterior performance/precision targets).
* **Do not use when:** priors cannot be justified or computation budget is limited.
* **Key inputs:** DGM, priors, candidate $N$, MCMC settings, assurance threshold (e.g., 80%/90%), performance/precision targets
* **Core output:** minimal $N$ meeting assurance threshold
* **Strengths:** coherent for Bayesian workflows; directly targets posterior criteria
* **Weaknesses:** computationally intensive; requires prior specification

#### D. Validation / Updating (for existing models)

**D8 ‚Äî AUC Precision (Hanley‚ÄìMcNeil / presize)**
* **Use when:** your validation goal is precision of AUC (CI width).
* **Do not use when:** calibration (slope/CITL) is the primary concern‚Äîthis method targets AUC only.
* **Key inputs:** expected AUC, prevalence or case-control ratio, confidence level, target CI width
* **Core output:** minimum $N$ to achieve desired AUC CI width
* **Strengths:** simple; quick planning for discrimination precision
* **Weaknesses:** approximate variance; ignores calibration

**D9 ‚Äî External Validation (Tailored; pmvalsampsize / sampsizeval)**
* **Use when:** you want validation sizing targeting multiple performance measures (calibration + discrimination), often requiring assumptions about the LP distribution.
* **Do not use when:** you cannot justify LP distribution assumptions or expected performance.
* **Key inputs:** prevalence, expected AUC, calibration slope/CITL targets, CI widths or SE targets, LP distribution assumptions
* **Core output:** recommended $N$ meeting precision criteria across measures
* **Strengths:** tailored; calibration-aware
* **Weaknesses:** requires additional assumptions; more complex

**D10 ‚Äî External Validation (Simulation; LP-based)**
* **Use when:** you can specify/estimate the distribution of the linear predictor (LP) in the target validation population and want simulation-based precision planning.
* **Do not use when:** LP distribution is unknown and cannot be approximated.
* **Key inputs:** LP distribution (normal/beta/empirical), miscalibration parameters, CI width targets for metrics, replicates, seed
* **Core output:** minimal $N$ achieving precision targets under simulation
* **Strengths:** very flexible; matches "simulate what you expect"
* **Weaknesses:** assumptions-heavy; computational cost

**D11 ‚Äî Updating / Recalibration (intercept/slope)**
* **Use when:** you will recalibrate an existing model (update intercept and/or slope) and need adequate precision.
* **Do not use when:** you are developing a brand-new model (use C5‚ÄìC7).
* **Key inputs:** updating type (intercept only vs intercept+slope), event rate, precision targets
* **Core output:** $N$ sufficient for stable updating
* **Strengths:** practical for real-world deployment
* **Weaknesses:** depends on local case-mix and model transportability assumptions

---

#### disclaimer

No clinical warranty; users are responsible for validation and interpretation. Always document assumptions and run sensitivity analyses.

#### Contact

Author & Maintenance: Minh Nguyen (minhnt@ump.edu.vn)
""",

        "a2_content_md": """
### What this is

This module estimates the **minimum sample size (n)** needed to estimate the **baseline risk / event rate** (p) (i.e., prevalence of the outcome) with a **desired precision**, expressed as a **confidence interval (CI) half-width** (margin of error).

It is useful for:
* describing the outcome prevalence in a cohort with a specified precision,
* planning feasibility and reporting baseline risk,
* supporting calibration-related planning (e.g., calibration-in-the-large relies on the event rate).

**Important limitation:** This calculation **does not** ensure prediction model performance (AUC, calibration slope, optimism). It only targets precision for estimating (p).

---

### Inputs (what they mean)

1. **Outcome prevalence / event rate** (p)
   Expected proportion of events in the target population (e.g., 0.10).
   * If unknown, consider a plausible range and run a sensitivity analysis.
   * If you want a conservative ‚Äúworst-case‚Äù for prevalence precision, use (p=0.50) (maximizes variance).

2. **Target half-width (margin of error)** (d)
   Desired precision such that the CI is approximately:
   $p \pm d$
   Examples: (d = 0.01, 0.02, 0.03) (i.e., ¬±1%, ¬±2%, ¬±3%).

3. **Confidence level** (1-$\\alpha$)
   Typical values: 0.95 or 0.99.

4. **CI Method**
* **Wilson score (recommended):** better coverage than Wald, especially when (p) is near 0 or 1 or sample size is modest.
* **Wald (normal approximation):** simple closed form but can perform poorly for small (n) or extreme (p).
* **Clopper‚ÄìPearson (exact):** conservative (often yields wider CIs; thus larger (n)).

---

### Core calculation

Let $X \sim \\text{Binomial}(n,p)$, $\hat p = X/n$. The goal is to find the smallest (n) such that the chosen CI method yields:
$$
\\frac{\\text{Upper}(n) - \\text{Lower}(n)}{2} \le d
$$

#### A) Wald (closed-form approximation)
$$ n \\approx \\frac{z^2 p(1-p)}{d^2} $$
**Note:** Fast but not recommended for small n or extreme p.

#### B) Wilson score interval (recommended)
Uses the Wilson score interval formula to find n. Since the interval depends on the observed count x, we iterate to find the smallest n where the half-width constraint is met for expected outcomes.

#### C) Clopper‚ÄìPearson ‚Äúexact‚Äù interval
Uses Beta quantiles to form conservative intervals. Typically yields larger sample sizes.

---

### Practical defaults

* **Confidence level:** 95% is standard.
* **Half-width (d):** ¬±0.01 to ¬±0.03 (1%‚Äì3%) are common targets.
* **Method:** Wilson is a strong default.

### Key references
1. **Wilson EB.** Probable inference, the law of succession, and statistical inference. *JASA.* 1927.
2. **Newcombe RG.** Two-sided confidence intervals for the single proportion. *Stat Med.* 1998.
""",

        "b3_content_md": """
### Purpose (what this method is)

This module estimates the **minimum sample size** needed to detect an association between a predictor (X) and a **binary outcome** (Y) using **logistic regression**, targeting a specified **odds ratio (OR)**, **two-sided ($\\alpha$)**, and **power**.

This is a **prognostic factor / association-focused** power calculation (testing a regression coefficient), **not** a prediction-model performance method. It does **not** guarantee good calibration or discrimination of a multivariable prediction model.

---

### When to use

Use B3 when:

* You want power to detect a **clinically meaningful OR** for a **single predictor** (binary or continuous) in logistic regression.
* Your primary goal is **hypothesis testing** (is the predictor associated with the outcome?), not building a risk prediction model.

### When NOT to use

Do not use B3 as your main approach when:

* Your goal is **prediction model development** (use Riley/pmsampsize or simulation/assurance methods).
* You plan **data-driven variable selection**, many interactions/splines, or complex machine-learning tuning (power for a single coefficient is not the right target).
* Data are **clustered** (multicenter/ward-level correlation) or strongly dependent without adjusting the design effect.
* You have a **case‚Äìcontrol** design with fixed case/control sampling (baseline risks ($p_0$) may not represent the source population).

---

## Statistical model and parameters

Logistic regression model:
$$
\\text{logit}{P(Y=1\\mid X)}=\\beta_0+\\beta_1 X
$$

* For **binary** ($X\\in\\{0,1\\}$):
  $$
  \\mathrm{OR}=\\exp(\\beta_1)
  $$
* For **continuous** ($X$): OR must be defined for a specific change in ($X$), commonly **1 SD increase**.

Hypothesis test:
$$
H_0:\\beta_1=0 \\quad \\text{vs}\\quad H_1:\\beta_1\\neq 0
$$

---

## Inputs (what each value means)

1. **Alpha (two-sided)** ($\\alpha$)
   Common choices: 0.05 (standard), 0.01 (more stringent).

2. **Power** ($1-\\beta$)
   Common choices: 0.80 (standard), 0.90 (more conservative).

3. **Baseline event rate** ($p_0$)

   * For **binary predictor**: ($p_0 = P(Y=1\\mid X=0)$) (event rate in the reference group).
   * For **continuous predictor**: ($p_0$) is typically interpreted as the event rate at the **mean** of ($X$) (after centering).

4. **Target odds ratio** ($\\mathrm{OR}$)
   The smallest OR that is clinically meaningful and worth detecting.

5. **Predictor type**

* **Binary predictor**: requires **prevalence of (X=1)**, denoted ($q=P(X=1)$).
* **Continuous predictor**: typically requires the OR for a **1 SD increase** (or you must convert using SD).

6. **($R^2$) with other covariates**
   ($R^2$) is the squared multiple correlation from regressing ($X$) on other covariates in a multivariable model.

   * If ($X$) is correlated with other predictors, the effective information about ($\\beta_1$) decreases, so the required sample size increases.

---

# Calculation

## Step 1 ‚Äî Convert OR and baseline risk to ($p_1$) (binary ($X$))

If ($X$) is binary, compute the event rate in the exposed group ($p_1=P(Y=1\\mid X=1)$) from ($p_0$) and OR:

$$
\\text{odds}_0=\\frac{p_0}{1-p_0},\\quad \\text{odds}_1=\\mathrm{OR}\\cdot \\text{odds}_0,\\quad
p_1=\\frac{\\text{odds}_1}{1+\\text{odds}_1}
$$

Overall event rate:
$$
p=(1-q)p_0+q p_1
$$

## Step 2 ‚Äî Z-scores

Let:
$$
z_{\\alpha}=z_{1-\\alpha/2}, \\qquad z_{\\beta}=z_{1-\\beta}=z_{\\text{power}}
$$

## A) Binary predictor sample size (Hsieh approach)

With ($q=P(X=1)$), ($p_0=P(Y=1\\mid X=0)$), ($p_1=P(Y=1\\mid X=1)$), and ($p$) as above:

$$
n_0=
\\frac{
\\left[
z_{\\alpha}\\sqrt{\\frac{p(1-p)}{q(1-q)}}
+
z_{\\beta}\\sqrt{\\frac{p_1(1-p_1)}{q}+\\frac{p_0(1-p_0)}{1-q}}
\\right]^2
}
{(p_1-p_0)^2}
$$

### Adjustment for correlation with other covariates

If you plan a multivariable model and the predictor of interest ($X$) correlates with other covariates, inflate the sample size using:

$$
n=\\frac{n_0}{1-R^2}
$$

### Expected number of events

$$
E \\approx n\\cdot p
$$

---

## B) Continuous predictor sample size (Hsieh approach)

Assume a logistic model with a continuous predictor ($X$) and define OR for a **1 SD increase** in ($X$), denoted ($\\mathrm{OR}_{SD}$). Let ($p_0$) be the event rate at the mean of ($X$):

$$
n_0=\\frac{(z_{\\alpha}+z_{\\beta})^2}{p_0(1-p_0)[\\log(\\mathrm{OR}_{SD})]^2}
$$

If the user has an OR per 1-unit increase, ($\\mathrm{OR}_{unit}$), and SD of ($X$) is ($\\sigma_X$), convert:
$$
\\log(\\mathrm{OR}_{SD})=\\log(\\mathrm{OR}_{unit})\\cdot \\sigma_X
$$

Then apply the same multivariable correlation inflation:
$$
n=\\frac{n_0}{1-R^2}
$$

---

## Practical guidance: what values to choose (common conventions)

* **($\\alpha$)**: 0.05 (two-sided) is typical; use smaller ($\\alpha$) if multiple testing is expected.
* **Power**: 0.80 is common; 0.90 is preferred when missing the effect would be costly.
* **OR**: choose the **minimum clinically meaningful** OR (often in the 1.2‚Äì2.0 range depending on context).
* **Baseline risk ($p_0$)**: use local hospital/cohort data if available; otherwise use literature estimates and run sensitivity analyses.
* **Binary predictor prevalence ($q$)**: use local prevalence; note ($q$) near 0.5 gives the **largest information** (smaller ($n$)); very small/large ($q$) increases required ($n$).
* **($R^2$)**: if uncertain, run a sensitivity range (e.g., 0, 0.1, 0.25, 0.5). Even moderate correlation can inflate ($n$) substantially via ($1/(1-R^2)$).
* **Continuous predictors**: consider standardizing ($X$) to mean 0, SD 1 so ($\\mathrm{OR}_{SD}$) is easy to interpret.

---

## Key references (2‚Äì5)

1. Hsieh FY, Bloch DA, Larsen MD. *A simple method of sample size calculation for linear and logistic regression.* Statistics in Medicine. 1998;17(14):1623‚Äì1634.
2. Hsieh FY. *Sample size tables for logistic regression.* Statistics in Medicine. 1989;8(7):795‚Äì802.
3. Whittemore AS. *Sample size for logistic regression with small response probability.* Journal of the American Statistical Association. 1981;76:27‚Äì32.
""",
        "c5_content_md": """
### What this method is

C5 implements the **Riley et al. analytical minimum sample size criteria** for **developing a multivariable clinical prediction model** with a **binary outcome** (logistic regression). The goal is to ensure the development dataset is large enough to:

1. **Limit overfitting** (via a target global shrinkage / calibration slope),
2. Achieve **adequate precision** for model performance (via a bound on optimism in $R^2$), and
3. Estimate the **overall outcome risk** (intercept/baseline risk) with acceptable precision.

This is a **model development** method (not external validation). It is particularly suitable when you plan a **pre-specified model form** (predictors and coding defined in advance) and want a **principled alternative to EPV rules**.

---

### When to use

Use C5 when:

* You are **developing** a new prediction model for a **binary outcome**.
* You can specify (even approximately) the **event rate** and an anticipated **overall model performance** (Cox‚ÄìSnell $R^2$ or AUC).
* You want to target **low overfitting** (e.g., shrinkage $S \\ge 0.90$) and reasonable precision.

### When NOT to use (or use with caution)

Do not rely on C5 alone when:

* You will do extensive **data-driven variable selection**, multiple interactions/splines, or heavy ML tuning without adjusting the **effective number of parameters (df)**.
* Your data are strongly **clustered** (multicenter) without accounting for design effects.
* The intended modeling approach is not standard logistic regression (e.g., complex ML) unless you map complexity to an appropriate **effective df** or switch to simulation-based sizing.
* You cannot justify any plausible performance input (AUC/$R^2$); in that case run wide sensitivity analyses and consider simulation-based methods.

---

## Key inputs (what each means)

1. **Outcome prevalence / event rate** (p)
   Expected proportion with (Y=1) in the development dataset.

2. **Number of predictor parameters (df)** (P)
   Total degrees of freedom for all candidate predictors **excluding the intercept**.
   Include: dummy variables, spline bases, interactions (and any other basis expansions).

3. **Anticipated performance** (choose one)

* **Cox‚ÄìSnell ($R^2_{CS}$)**: preferred if available from related prior studies (ideally optimism-adjusted).
* **AUC (C-statistic)**: if $R^2_{CS}$ is unavailable, the tool can approximate $R^2_{CS}$ from AUC and ($p$) using a published approach.
* **Conservative (15% of max $R^2$)**: a fallback when neither AUC nor $R^2$ is available; use with caution.

4. **Target global shrinkage** (S)
   A target for **overall overfitting control** (often interpreted similarly to an expected calibration slope after internal validation).

* Common default: $S = 0.90$ ($\\approx$ 10% shrinkage of predictor effects).
* More conservative: $S = 0.95$ (requires larger sample size).

---

## Core concepts and formulas

### Cox‚ÄìSnell ($R^2$) and its maximum

Cox‚ÄìSnell ($R^2$) for a fitted logistic model can be written as:
$$
R^2_{CS} = 1-\\exp\\left(\\frac{2}{n}(\\ell_0-\\ell_1)\\right),
$$
where $\\ell_0$ is the intercept-only log-likelihood and $\\ell_1$ is the model log-likelihood.

For binary outcomes, $R^2_{CS}$ cannot reach 1. Its maximum depends on the outcome prevalence:
$$
\\ell_0 = n\\Big[p\\ln(p) + (1-p)\\ln(1-p)\\Big],
$$
$$
R^2_{CS,\\max}=1-\\exp\\left(\\frac{2\\ell_0}{n}\\right)
=1-\\exp\\Big(2[p\\ln(p) + (1-p)\\ln(1-p)]\\Big).
$$

Nagelkerke ($R^2$) rescales Cox‚ÄìSnell ($R^2$) to ([0,1]):
$$
R^2_{Nag}=\\frac{R^2_{CS}}{R^2_{CS,\\max}}.
$$

---

## The three Riley criteria (binary outcome)

### Criterion 1 ‚Äî Control overfitting via target shrinkage (S)

Minimum sample size to target global shrinkage (S):
$$
n_1=\\left\\lceil
\\frac{P}{(S-1)\\ln\\left(1-\\frac{R^2_{CS}}{S}\\right)}
\\right\\rceil.
$$

### Criterion 2 ‚Äî Limit optimism in ($R^2$) (default absolute difference 0.05)

This criterion targets a small absolute difference (default $\\delta=0.05$) between apparent and adjusted **Nagelkerke** ($R^2$). The required shrinkage implied by this constraint is:
$$
S_{\\delta}=\\frac{R^2_{CS}}{R^2_{CS}+\\delta R^2_{CS,\\max}}.
$$
Then:
$$
n_2=\\left\\lceil
\\frac{P}{(S_{\\delta}-1)\\ln\\left(1-\\frac{R^2_{CS}}{S_{\\delta}}\\right)}
\\right\\rceil.
$$

### Criterion 3 ‚Äî Precise estimation of the overall outcome risk (intercept)

This targets precision of the **average outcome risk** ($p$) (baseline risk) within ($\\pm d$) on the probability scale (default $d=0.05$ at 95% CI):
$$
n_3=\\left\\lceil
\\left(\\frac{z_{1-\\alpha/2}}{d}\\right)^2 p(1-p)
\\right\\rceil,
\\quad \\text{default } z_{0.975}=1.96,; d=0.05.
$$

### Final recommendation

$$
n_{\\min}=\\max(n_1,n_2,n_3),\\qquad
E = n_{\\min}p,\\qquad
EPP=\\frac{E}{P}.
$$

---

## Practical guidance (typical choices)

* **Shrinkage (S)**: use **0.90** as a standard target; consider **0.95** if you want stronger overfitting control or if the model is complex.
* **$\\delta=0.05$** for Criterion 2: commonly kept at the default.
* **Intercept precision (d=0.05)**: default corresponds to estimating baseline risk within ¬±5%. If baseline risk must be estimated more precisely, you would need a smaller ($d$) (larger ($n$)).
* **Anticipated ($R^2_{CS}$)**:

  * Prefer **optimism-adjusted** values from related studies (or apparent values from external validation data).
  * If only AUC is available, use the published AUC‚Üí$R^2_{CS}$ approximation method.
  * If neither is available, the **15% of $R^2_{CS,\\max}$** option is a conservative fallback for exploratory planning‚Äîalways run sensitivity analyses.

---

## Key references (2‚Äì5)

1. Riley RD, Snell KIE, Ensor J, et al. *Minimum sample size required for developing a multivariable prediction model: PART II‚Äîbinary and time-to-event outcomes.* Statistics in Medicine. 2019.
2. Riley RD, Ensor J, Snell KIE, et al. *Calculating the sample size required for developing a clinical prediction model.* BMJ. 2020.
3. Riley RD, Van Calster B, Collins GS. *A note on estimating the Cox‚ÄìSnell ($R^2$) from a reported C statistic (AUROC) to inform sample size calculations for developing a prediction model with a binary outcome.* Statistics in Medicine. 2021.
4. Harrell FE Jr, Lee KL, Mark DB. *Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.* Statistics in Medicine. 1996.
""",
    },
    "VI": {
        "title": "Prognostic Research Sample Size Tool",
        "sidebar_title": "C·∫•u h√¨nh",
        "language": "Ng√¥n ng·ªØ / Language",
        "mode": "Ch·ªçn Ph∆∞∆°ng ph√°p",
        "mode_riley": "Ph∆∞∆°ng ph√°p 1: Riley et al. (C√¥ng th·ª©c)",
        "mode_bayes": "Ph∆∞∆°ng ph√°p 2: Bayesian Assurance (M√¥ ph·ªèng)",
        "mode_single": "K·ªãch b·∫£n ƒë∆°n (Single)",
        "mode_batch": "Ph√¢n t√≠ch ƒë·ªô nh·∫°y (Nhi·ªÅu gi√° tr·ªã)",
        "method1_tab": "Ph∆∞∆°ng ph√°p 1 (Riley)",
        "method2_tab": "Ph∆∞∆°ng ph√°p 2 (Bayesian)",
        "nav_title": "ƒêi·ªÅu h∆∞·ªõng",
        "nav_intro": "Gi·ªõi thi·ªáu & C√¥ng th·ª©c",
        "nav_calc": "C√¥ng c·ª• t√≠nh to√°n",
        "intro_heading": "Gi·ªõi thi·ªáu",
        "intro_text": "·ª®ng d·ª•ng h·ªó tr·ª£ ∆∞·ªõc t√≠nh c·ª° m·∫´u t·ªëi thi·ªÉu cho m√¥ h√¨nh d·ª± b√°o l√¢m s√†ng (bi·∫øn nh·ªã ph√¢n).",
        "formula_heading": "C∆° s·ªü To√°n h·ªçc (Ph∆∞∆°ng ph√°p 1)",
        "formula_intro": "Ph∆∞∆°ng ph√°p 1 d√πng c√¥ng th·ª©c gi·∫£i t√≠ch (Riley), Ph∆∞∆°ng ph√°p 2 d√πng m√¥ ph·ªèng Bayesian MCMC.",
        "sens_guide_title": "üí° H∆∞·ªõng d·∫´n nh·∫≠p Ph√¢n t√≠ch ƒê·ªô nh·∫°y",
        "sens_guide_text": """
        - **Kho·∫£ng gi√° tr·ªã**: Nh·∫≠p `min-max` (VD: `0.05-0.10`).
        - **Danh s√°ch gi√° tr·ªã**: Nh·∫≠p d·∫•u ph·∫©y (VD: `0.05, 0.10, 0.15`).
        """,
        "detail_view": "Xem chi ti·∫øt",
        "footer_refs": "T√†i li·ªáu tham kh·∫£o: Riley et al. (2018, 2020), BayesAssurance.",
        "calc_btn": "T√≠nh to√°n",
        "results": "K·∫øt qu·∫£",
        "sanity": "Ki·ªÉm tra nhanh (EPV)",
        "download_csv": "T·∫£i xu·ªëng CSV",
        "download_report": "T·∫£i B√°o c√°o ƒê·∫ßy ƒë·ªß",
        "error_p": "T·ª∑ l·ªá ph·∫£i t·ª´ 0 ƒë·∫øn 1.",
        "error_auc": "AUC ph·∫£i t·ª´ 0.5 ƒë·∫øn 1.",
        "error_parse": "L·ªói nh·∫≠p li·ªáu.",
        
        # Riley specific
        "riley_inputs": "Tham s·ªë ƒë·∫ßu v√†o (Riley)",
        "prevalence": "T·ª∑ l·ªá bi·∫øn c·ªë (Prevalence)",
        "prevalence_help": "T·ª∑ l·ªá ng∆∞·ªùi c√≥ bi·∫øn c·ªë (0 < p < 1).",
        "parameters": "S·ªë tham s·ªë d·ª± b√°o (df)",
        "parameters_help": "T·ªïng b·∫≠c t·ª± do c·ªßa c√°c bi·∫øn (tr·ª´ intercept).",
        "shrinkage": "H·ªá s·ªë co tr∆∞·ª£t (Shrinkage)",
        "shrinkage_help": "H·ªá s·ªë S mong mu·ªën (m·∫∑c ƒë·ªãnh 0.9).",
        "perf_measure": "Hi·ªáu nƒÉng d·ª± ki·∫øn",
        "perf_auc": "AUC (C-statistic)",
        "perf_r2": "Cox-Snell R-squared",
        "perf_cons": "Th·∫≠n tr·ªçng (Conservative)",
        
        # Bayesian specific
        "bayes_inputs": "C√†i ƒë·∫∑t M√¥ ph·ªèng (Bayesian Assurance)",
        "dgm_settings": "C∆° ch·∫ø Sinh D·ªØ li·ªáu (DGM)",
        "sim_settings": "C√†i ƒë·∫∑t M√¥ ph·ªèng & MCMC",
        "eval_settings": "Ti√™u chu·∫©n ƒê√°nh gi√°",
        "n_candidates": "C√°c m·ª©c C·ª° m·∫´u th·ª≠ nghi·ªám (c√°ch nhau b·ªüi d·∫•u ph·∫©y)",
        "n_candidates_help": "Danh s√°ch N mu·ªën ki·ªÉm tra, VD: 500, 1000, 1500.",
        "correlation": "H·ªá s·ªë t∆∞∆°ng quan (rho)",
        "n_sims": "S·ªë l·∫ßn m√¥ ph·ªèng cho m·ªói N",
        "assurance_threshold": "Ng∆∞·ª°ng Assurance (X√°c su·∫•t ƒë·∫°t y√™u c·∫ßu)",
        "run_simulation": "Ch·∫°y M√¥ ph·ªèng",
        "simulation_running": "ƒêang ch·∫°y m√¥ ph·ªèng... Vui l√≤ng ƒë·ª£i.",
        "assurance_result": "Ph√¢n t√≠ch Assurance",

        # Method 6 (Dev Sim)
        "mode_dev_sim": "Ph∆∞∆°ng ph√°p 6: M√¥ ph·ªèng Ph√°t tri·ªÉn (Freq)",
        "method6_tab": "PP 6 (M√¥ ph·ªèng)",
        "dev_sim_intro": "T√≠nh c·ª° m·∫´u ph√°t tri·ªÉn m√¥ h√¨nh d·ª±a tr√™n m√¥ ph·ªèng (theo ph∆∞∆°ng ph√°p `samplesizedev`).",
        "dev_mode_simple": "Ch·∫ø ƒë·ªô A: ƒê∆°n gi·∫£n (theo AUC)",
        "dev_mode_custom": "Ch·∫ø ƒë·ªô B: DGM T√πy ch·ªânh",
        "target_auc": "AUC M·ª•c ti√™u (C-statistic trung b√¨nh)",
        "target_auc_help": "Thu·∫≠t to√°n s·∫Ω t·ª± t√¨m h·ªá s·ªë Beta ƒë·ªÉ ƒë·∫°t AUC n√†y.",
        "criteria_settings": "Ti√™u ch√≠ ƒê·∫°t (Pass/Fail)",
        "crit_slope_mean": "Calibration Slope TB >= 0.9",
        "crit_slope_ci": "Pr(0.9 <= Slope <= 1.1) >= 80%",
        "crit_auc": "AUC TB >= M·ª•c ti√™u",
        "audit_trail": "RNG Audit Trail (JSON)",
        "future_methods": "S·∫Øp ra m·∫Øt...",

        # Quick Methods
        "method_quick_tab": "A. Nhanh / C∆° b·∫£n",
        "quick_mode_epv": "A1: Quy t·∫Øc EPV / EPP (Kinh nghi·ªám)",
        "quick_mode_risk": "A2: ∆Ø·ªõc l∆∞·ª£ng T·ª∑ l·ªá n·ªÅn (ƒê·ªô r·ªông CI)",
        "target_epv": "S·ªë bi·∫øn c·ªë tr√™n tham s·ªë m·ª•c ti√™u (EPP)",
        "target_epv_help": "Gi√° tr·ªã th∆∞·ªùng d√πng: 10, 15, 20. EPP t·ªët h∆°n EPV.",
        "epv_warning_title": "‚ö†Ô∏è C·∫£nh b√°o Quan tr·ªçng",
        "epv_warning_text": "EPV/EPP ch·ªâ l√† quy t·∫Øc kinh nghi·ªám th√¥. N√≥ KH√îNG ƒë·∫£m b·∫£o ƒë·ªô ch√≠nh x√°c, ph√¢n bi·ªát hay ngƒÉn ng·ª´a overfitting. R·∫•t nh·∫°y c·∫£m v·ªõi vi·ªác ch·ªçn bi·∫øn v√† ƒëa c·ªông tuy·∫øn.",
        "ci_level": "ƒê·ªô tin c·∫≠y (Confidence Level)",
        "ci_half_width": "B√°n k√≠nh CI mong mu·ªën (Sai s·ªë bi√™n)",
        "ci_method": "Ph∆∞∆°ng ph√°p CI",
        "ci_method_wilson": "Wilson Score (Khuy√™n d√πng)",
        "ci_method_wald": "Wald (ƒê∆°n gi·∫£n)",
        "ci_method_cp": "Clopper-Pearson (Th·∫≠n tr·ªçng)",
        "risk_help": "T√≠nh N ƒë·ªÉ ∆∞·ªõc l∆∞·ª£ng t·ª∑ l·ªá p v·ªõi ƒë·ªô ch√≠nh x√°c nh·∫•t ƒë·ªãnh. KH√îNG ƒë·∫£m b·∫£o hi·ªáu nƒÉng m√¥ h√¨nh d·ª± b√°o.",
        
        # Power Methods (B)
        "title_b3": "B3: Logistic Power (Hsieh)",
        "title_b4": "B4: Cox Power (Schoenfeld)",
        "interpretation": "Gi·∫£i th√≠ch k·∫øt qu·∫£",
        
        # Validations (D)
        "title_d8": "D8: AUC Precision (Hanley-McNeil)",
        "d8_desc": "Calculate sample size for estimating AUC with desired precision (CI width).",
        "auc_expected": "AUC d·ª± ki·∫øn (C-statistic)",
        "formulas_header": "üìö C√¥ng th·ª©c & Chi ti·∫øt k·ªπ thu·∫≠t",
        "d8_assumptions": "**Gi·∫£ ƒë·ªãnh**: S·ª≠ d·ª•ng x·∫•p x·ªâ ph∆∞∆°ng sai Hanley & McNeil (1982). Gi·∫£ ƒë·ªãnh ph√¢n ph·ªëi chu·∫©n ƒë·ªëi x·ª©ng cho AUC. T·ªëi ∆∞u h√≥a s·ªë h·ªçc ƒë·ªÉ t√¨m N.",
        "d8_mode_n_to_width": "T√≠nh ƒë·ªô r·ªông CI t·ª´ N",
        "d8_mode_width_to_n": "T√≠nh N t·ª´ ƒë·ªô r·ªông CI",
        "d8_opt_settings": "C√†i ƒë·∫∑t T·ªëi ∆∞u h√≥a N√¢ng cao",
        "d8_practical_rounding": "Hi·ªÉn th·ªã l√†m tr√≤n s·ªë nguy√™n (Th·ª±c t·∫ø)",
        "d8_n_input": "C·ª° m·∫´u (N)",
        "d8_width_input": "ƒê·ªô r·ªông CI (T·ªïng)",
        "d8_opt_bound": "C·∫≠n tr√™n t√¨m ki·∫øm (Upper Limit)",
        "d8_opt_tol": "Dung sai (Tolerance)",
        
        # D9
        "title_d9": "D9: Th·∫©m ƒë·ªãnh ngo√†i (Tailored)",
        "common_inputs": "Tham s·ªë chung",
        
        # UI Basics
        "intro_heading": "Ch√†o m·ª´ng ƒë·∫øn v·ªõi Prognostic Research Sample Size Tool",
        "search_placeholder": "T√¨m ph∆∞∆°ng ph√°p...",
        "settings": "C√†i ƒë·∫∑t",

        # Footer
        "footer_copyright": "¬© 2026 Prognostic Research Sample Size Tool. D√†nh cho nghi√™n c·ª©u/h·ªçc thu·∫≠t. Kh√¥ng b√°n th∆∞∆°ng m·∫°i.",
        "footer_author": "T√°c gi·∫£ & B·∫£o tr√¨: Minh Nguyen (minhnt@ump.edu.vn)",
        "footer_disclaimer": "Mi·ªÖn tr·ª´ tr√°ch nhi·ªám: Kh√¥ng ƒë·∫£m b·∫£o t√≠nh ·ª©ng d·ª•ng l√¢m s√†ng; ng∆∞·ªùi d√πng t·ª± ch·ªãu tr√°ch nhi·ªám ki·ªÉm ƒë·ªãnh.",

        "intro_complete_md": """
### Ch√†o m·ª´ng

·ª®ng d·ª•ng n√†y gi√∫p c√°c nh√† l√¢m s√†ng v√† nh√† nghi√™n c·ª©u t√≠nh to√°n c·ª° m·∫´u t·ªëi thi·ªÉu cho nghi√™n c·ª©u ti√™n l∆∞·ª£ng, bao g·ªìm:
* Nghi√™n c·ª©u y·∫øu t·ªë ti√™n l∆∞·ª£ng (power ƒë·ªÉ ph√°t hi·ªán li√™n quan),
* X√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o l√¢m s√†ng (prediction model development), v√†
* Th·∫©m ƒë·ªãnh/ngo·∫°i ki·ªÉm & c·∫≠p nh·∫≠t m√¥ h√¨nh (validation/updating).

·ª®ng d·ª•ng ph√π h·ª£p cho k·∫øt c·ª•c nh·ªã ph√¢n (c√≥/kh√¥ng bi·∫øn c·ªë) v√† m·ªôt s·ªë m√¥-ƒëun cho k·∫øt c·ª•c th·ªùi gian s·ªëng (Cox PH).

M√£ ngu·ªìn (t·∫£i v·ªÅ): [https://gitlab.com/minhthiennguyen/pmsample/](https://gitlab.com/minhthiennguyen/pmsample/)
ho·∫∑c [https://github.com/nguyenminh2301/pmsample.git](https://github.com/nguyenminh2301/pmsample.git)

### H∆∞·ªõng d·∫´n nhanh cho ng∆∞·ªùi m·ªõi

#### 1. X√°c ƒë·ªãnh m·ª•c ti√™u nghi√™n c·ª©u
* B·∫°n mu·ªën ki·ªÉm ƒë·ªãnh m·ªôt y·∫øu t·ªë ti√™n l∆∞·ª£ng (li√™n quan OR/HR)?
* B·∫°n mu·ªën x√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o?
* B·∫°n mu·ªën ngo·∫°i ki·ªÉm m√¥ h√¨nh c√≥ s·∫µn ·ªü qu·∫ßn th·ªÉ m·ªõi?

#### 2. ∆Ø·ªõc t√≠nh t·ª∑ l·ªá bi·∫øn c·ªë $p$ (ho·∫∑c t·ª∑ l·ªá bi·∫øn c·ªë t√≠ch l≈©y cho s·ªëng c√≤n)
* ∆Øu ti√™n l·∫•y t·ª´ d·ªØ li·ªáu b·ªánh vi·ªán (best).
* N·∫øu ch∆∞a ch·∫Øc, nh·∫≠p kho·∫£ng gi√° tr·ªã v√† ch·∫°y ƒë·ªô nh·∫°y.

#### 3. ƒê·∫øm ƒë√∫ng ƒë·ªô ph·ª©c t·∫°p m√¥ h√¨nh (tham s·ªë/df)
C·∫ßn d√πng s·ªë tham s·ªë (df), kh√¥ng ch·ªâ "s·ªë bi·∫øn". Quy t·∫Øc c∆° b·∫£n:
* Bi·∫øn nh·ªã ph√¢n: 1 df
* Bi·∫øn ph√¢n lo·∫°i $L$ m·ª©c: $L-1$ df
* Spline RCS $K$ n√∫t: $K-1$ df
* T∆∞∆°ng t√°c: $df(A \\times B) = df(A) \\cdot df(B)$

#### 4. Ch·ªçn ph∆∞∆°ng ph√°p ph√π h·ª£p
* **"Quick tools"** ch·ªâ ƒë·ªÉ ki·ªÉm tra s∆° b·ªô.
* N·∫øu x√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o: ∆∞u ti√™n **Riley / m√¥ ph·ªèng / assurance**.

---

### Khi n√†o n√™n d√πng (v√† khi n√†o kh√¥ng n√™n d√πng)

**N√™n d√πng khi:**
* L·∫≠p k·∫ø ho·∫°ch ƒëo√†n h·ªá h·ªìi c·ª©u/ti·∫øn c·ª©u trong ti√™n l∆∞·ª£ng/d·ª± b√°o
* X√¢y d·ª±ng/ngo·∫°i ki·ªÉm m√¥ h√¨nh d·ª± b√°o nguy c∆°
* C·∫ßn ∆∞·ªõc t√≠nh c·ª° m·∫´u theo ƒë·ªô ch√≠nh x√°c (ƒë·ªô r·ªông KTC) cho t·ª∑ l·ªá ho·∫∑c AUC
* Thi·∫øt k·∫ø ngo·∫°i ki·ªÉm v·ªõi m·ª•c ti√™u calibration + discrimination

**Kh√¥ng n√™n d√πng nh∆∞ c√¥ng c·ª• ch√≠nh khi:**
* Thi·∫øt k·∫ø th·ª≠ nghi·ªám ng·∫´u nhi√™n (RCT) (c·∫ßn ph∆∞∆°ng ph√°p c·ª° m·∫´u ri√™ng cho RCT)
* Nghi√™n c·ª©u ƒë·ªô ch√≠nh x√°c ch·∫©n ƒëo√°n (Se/Sp) kh√¥ng g·∫Øn v·ªõi m√¥ h√¨nh d·ª± b√°o
* Mong mu·ªën "m·ªôt con s·ªë ƒë√∫ng tuy·ªát ƒë·ªëi": c·ª° m·∫´u ph·ª• thu·ªôc gi·∫£ ƒë·ªãnh v√† c·∫ßn ph√¢n t√≠ch ƒë·ªô nh·∫°y

---

### Danh m·ª•c ph∆∞∆°ng ph√°p (t√≥m t·∫Øt)

#### A. Quick / Basic (nhanh, x·∫•p x·ªâ)

**A1 ‚Äî Quy t·∫Øc kinh nghi·ªám (EPV/EPP) (heuristic)**
* **D√πng khi:** c·∫ßn ki·ªÉm tra s∆° b·ªô "s·ªë bi·∫øn c·ªë c√≥ ƒë·ªß t∆∞∆°ng ƒë·ªëi kh√¥ng" theo ƒë·ªô ph·ª©c t·∫°p m√¥ h√¨nh.
* **Kh√¥ng d√πng khi:** c√≥ spline/t∆∞∆°ng t√°c/ch·ªçn bi·∫øn/bi·∫øn c·ªë hi·∫øm‚ÄîEPV/EPP kh√¥ng ƒë·∫£m b·∫£o calibration ho·∫∑c √≠t optimism.
* **ƒê·∫ßu v√†o:** t·ª∑ l·ªá bi·∫øn c·ªë $p$, s·ªë tham s·ªë $P$ (df), EPP m·ª•c ti√™u (10/15/20)
* **ƒê·∫ßu ra:** $E=t \\cdot P$, $N=\\lceil E/p \\rceil$
* **M·∫°nh:** r·∫•t ƒë∆°n gi·∫£n, nhanh
* **Y·∫øu:** d·ªÖ g√¢y l·∫°c quan, kh√¥ng d·ª±a tr√™n hi·ªáu nƒÉng

**A2 ‚Äî ƒê·ªô ch√≠nh x√°c nguy c∆° n·ªÅn (KTC cho t·ª∑ l·ªá)**
* **D√πng khi:** m·ª•c ti√™u l√† ∆∞·ªõc t√≠nh t·ª∑ l·ªá bi·∫øn c·ªë $p$ v·ªõi KTC ƒë·ªß h·∫πp (¬±d).
* **Kh√¥ng d√πng khi:** mu·ªën ƒë·∫£m b·∫£o hi·ªáu nƒÉng m√¥ h√¨nh d·ª± b√°o.
* **ƒê·∫ßu v√†o:** $p$, ph∆∞∆°ng ph√°p KTC (Wilson khuy·∫øn ngh·ªã), m·ª©c tin c·∫≠y, n·ª≠a ƒë·ªô r·ªông $d$
* **ƒê·∫ßu ra:** $N$ t·ªëi thi·ªÉu ƒë·∫°t n·ª≠a ƒë·ªô r·ªông KTC $\\le d$
* **M·∫°nh:** minh b·∫°ch, tr·ª±c ti·∫øp theo m·ª•c ti√™u ƒë·ªô ch√≠nh x√°c
* **Y·∫øu:** ch·ªâ cho $p$, kh√¥ng n√≥i v·ªÅ AUC/slope

#### B. Prognostic factor (power) (t·∫≠p trung li√™n quan, kh√¥ng ph·∫£i sizing cho m√¥ h√¨nh d·ª± b√°o)

**B3 ‚Äî Logistic OR Power (Hsieh)**
* **D√πng khi:** c·∫ßn power ƒë·ªÉ ph√°t hi·ªán OR m·ª•c ti√™u c·ªßa m·ªôt y·∫øu t·ªë ti√™n l∆∞·ª£ng trong logistic regression.
* **Kh√¥ng d√πng khi:** m·ª•c ti√™u ch√≠nh l√† x√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o.
* **ƒê·∫ßu v√†o:** $p_0$, OR m·ª•c ti√™u, alpha, power, t·ª∑ l·ªá ph∆°i nhi·ªÖm (n·∫øu nh·ªã ph√¢n) ho·∫∑c SD (n·∫øu li√™n t·ª•c), t√πy ch·ªçn $R^2$ v·ªõi ƒë·ªìng bi·∫øn
* **ƒê·∫ßu ra:** $N$ (v√† s·ªë bi·∫øn c·ªë k·ª≥ v·ªçng)
* **M·∫°nh:** khung power kinh ƒëi·ªÉn
* **Y·∫øu:** kh√¥ng nh·∫Øm calibration/discrimination

**B4 ‚Äî Cox HR Power (Schoenfeld)**
* **D√πng khi:** k·∫øt c·ª•c s·ªëng c√≤n, c·∫ßn ph√°t hi·ªán HR m·ª•c ti√™u theo Cox PH.
* **Kh√¥ng d√πng khi:** kh√≥ ∆∞·ªõc l∆∞·ª£ng t·ª∑ l·ªá bi·∫øn c·ªë theo d√µi ho·∫∑c PH kh√¥ng h·ª£p l√Ω.
* **ƒê·∫ßu v√†o:** HR, alpha, power, t·ª∑ l·ªá ph√¢n b·ªï (nh·ªã ph√¢n) ho·∫∑c SD (li√™n t·ª•c), t·ª∑ l·ªá bi·∫øn c·ªë k·ª≥ v·ªçng trong th·ªùi gian theo d√µi
* **ƒê·∫ßu ra:** s·ªë bi·∫øn c·ªë c·∫ßn thi·∫øt ‚Üí suy ra $N$
* **M·∫°nh:** ph·ªï bi·∫øn, tr·ª±c quan theo s·ªë bi·∫øn c·ªë
* **Y·∫øu:** ph·ª• thu·ªôc m·∫°nh v√†o gi·∫£ ƒë·ªãnh theo d√µi/censoring

#### C. Prediction model development (khuy·∫øn ngh·ªã cho x√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o)

**C5 ‚Äî Riley et al. (ph√¢n t√≠ch; pmsampsize-like)**
* **D√πng khi:** ph√°t tri·ªÉn m√¥ h√¨nh d·ª± b√°o, c·∫ßn h·∫°n ch·∫ø overfitting v√† b·∫£o ƒë·∫£m ƒë·ªô ch√≠nh x√°c.
* **Kh√¥ng d√πng khi:** kh√¥ng c√≥ gi·∫£ ƒë·ªãnh h·ª£p l√Ω v·ªÅ $p$ v√† hi·ªáu nƒÉng d·ª± ki·∫øn (AUC ho·∫∑c $R^2$); khi ƒë√≥ d√πng ƒë·ªô nh·∫°y/m√¥ ph·ªèng.
* **ƒê·∫ßu v√†o:** $p$, $P$ (df), shrinkage m·ª•c ti√™u (v√≠ d·ª• 0,90), hi·ªáu nƒÉng d·ª± ki·∫øn (AUC ho·∫∑c Cox‚ÄìSnell $R^2$)
* **ƒê·∫ßu ra:** $N$ t·ªëi thi·ªÉu th·ªèa c√°c ti√™u ch√≠ (overfitting + precision)
* **M·∫°nh:** c√≥ c∆° s·ªü, d·ª±a tr√™n hi·ªáu nƒÉng
* **Y·∫øu:** ph·ª• thu·ªôc gi·∫£ ƒë·ªãnh; c·∫ßn ƒë·∫øm df chu·∫©n

**C6 ‚Äî Development Simulation (Frequentist; samplesizedev/custom DGM)**
* **D√πng khi:** mu·ªën m√¥ ph·ªèng theo ƒë√∫ng c√°ch b·∫°n d·ª± ki·∫øn x√¢y d·ª±ng m√¥ h√¨nh (phi tuy·∫øn/t∆∞∆°ng t√°c).
* **Kh√¥ng d√πng khi:** kh√¥ng m√¥ t·∫£ ƒë∆∞·ª£c DGM h·ª£p l√Ω ho·∫∑c c·∫ßn k·∫øt qu·∫£ t·ª©c th√¨.
* **ƒê·∫ßu v√†o:** danh s√°ch $N$, gi·∫£ ƒë·ªãnh DGM, ti√™u ch√≠ hi·ªáu nƒÉng, s·ªë m√¥ ph·ªèng, seed
* **ƒê·∫ßu ra:** $N$ nh·ªè nh·∫•t ƒë·∫°t ti√™u ch√≠
* **M·∫°nh:** linh ho·∫°t, ph√π h·ª£p m√¥ h√¨nh ph·ª©c t·∫°p
* **Y·∫øu:** t·ªën t√≠nh to√°n, nh·∫°y gi·∫£ ƒë·ªãnh

**C7 ‚Äî Bayesian Assurance (MCMC)**
* **D√πng khi:** m√¥ h√¨nh cu·ªëi c√πng ∆∞·ªõc l∆∞·ª£ng b·∫±ng Bayes/MCMC v√† mu·ªën sizing theo assurance.
* **Kh√¥ng d√πng khi:** kh√¥ng x√°c ƒë·ªãnh ƒë∆∞·ª£c prior h·ª£p l√Ω ho·∫∑c h·∫°n ch·∫ø compute.
* **ƒê·∫ßu v√†o:** DGM, prior, $N$, ti√™u ch√≠ assurance, c√†i ƒë·∫∑t MCMC
* **ƒê·∫ßu ra:** $N$ nh·ªè nh·∫•t ƒë·∫°t assurance
* **M·∫°nh:** nh·∫•t qu√°n v·ªõi Bayes
* **Y·∫øu:** compute cao, c·∫ßn prior

#### D. Validation / Updating (cho m√¥ h√¨nh c√≥ s·∫µn)

**D8 ‚Äî ƒê·ªô ch√≠nh x√°c AUC (Hanley‚ÄìMcNeil / presize)**
* **D√πng khi:** m·ª•c ti√™u ngo·∫°i ki·ªÉm l√† KTC AUC ƒë·ªß h·∫πp.
* **Kh√¥ng d√πng khi:** calibration l√† tr·ªçng t√¢m.
* **ƒê·∫ßu v√†o:** AUC k·ª≥ v·ªçng, $p$ ho·∫∑c t·ª∑ l·ªá case-control, m·ª©c tin c·∫≠y, ƒë·ªô r·ªông KTC m·ª•c ti√™u
* **ƒê·∫ßu ra:** $N$ t·ªëi thi·ªÉu cho ƒë·ªô ch√≠nh x√°c AUC
* **M·∫°nh:** nhanh, d·ªÖ d√πng
* **Y·∫øu:** ch·ªâ AUC, x·∫•p x·ªâ

**D9 ‚Äî External Validation (Tailored; pmvalsampsize / sampsizeval)**
* **D√πng khi:** sizing ngo·∫°i ki·ªÉm theo nhi·ªÅu th∆∞·ªõc ƒëo (calibration + discrimination), th∆∞·ªùng c·∫ßn gi·∫£ ƒë·ªãnh ph√¢n b·ªë LP.
* **Kh√¥ng d√πng khi:** kh√¥ng bi·ªán minh ƒë∆∞·ª£c gi·∫£ ƒë·ªãnh LP/case-mix.
* **ƒê·∫ßu v√†o:** $p$, AUC k·ª≥ v·ªçng, m·ª•c ti√™u slope/CITL, ƒë·ªô r·ªông KTC/SE, gi·∫£ ƒë·ªãnh ph√¢n b·ªë LP
* **ƒê·∫ßu ra:** $N$ khuy·∫øn ngh·ªã
* **M·∫°nh:** "tailored", ch√∫ tr·ªçng calibration
* **Y·∫øu:** ph·ª©c t·∫°p, ph·ª• thu·ªôc gi·∫£ ƒë·ªãnh

**D10 ‚Äî External Validation (Simulation; LP-based)**
* **D√πng khi:** c√≥ th·ªÉ m√¥ t·∫£/∆∞·ªõc l∆∞·ª£ng ph√¢n b·ªë LP ·ªü qu·∫ßn th·ªÉ ngo·∫°i ki·ªÉm v√† mu·ªën m√¥ ph·ªèng ƒë·ªô ch√≠nh x√°c.
* **Kh√¥ng d√πng khi:** kh√¥ng ∆∞·ªõc l∆∞·ª£ng ƒë∆∞·ª£c LP distribution.
* **ƒê·∫ßu v√†o:** ph√¢n b·ªë LP, tham s·ªë miscalibration, m·ª•c ti√™u ƒë·ªô r·ªông KTC, s·ªë m√¥ ph·ªèng, seed
* **ƒê·∫ßu ra:** $N$ t·ªëi thi·ªÉu theo m√¥ ph·ªèng
* **M·∫°nh:** linh ho·∫°t
* **Y·∫øu:** t·ªën compute, nh·∫°y gi·∫£ ƒë·ªãnh

**D11 ‚Äî Updating / Recalibration (intercept/slope)**
* **D√πng khi:** c·∫ßn c·∫≠p nh·∫≠t intercept/slope khi tri·ªÉn khai ·ªü b·ªánh vi·ªán m·ªõi.
* **Kh√¥ng d√πng khi:** ph√°t tri·ªÉn m√¥ h√¨nh m·ªõi ho√†n to√†n.
* **ƒê·∫ßu v√†o:** ki·ªÉu c·∫≠p nh·∫≠t, $p$, m·ª•c ti√™u ƒë·ªô ch√≠nh x√°c
* **ƒê·∫ßu ra:** $N$ ƒë·ªß ·ªïn ƒë·ªãnh cho c·∫≠p nh·∫≠t
* **M·∫°nh:** th·ª±c d·ª•ng khi tri·ªÉn khai
* **Y·∫øu:** ph·ª• thu·ªôc case-mix v√† transportability

---

#### Disclaimer

No clinical warranty; users are responsible for validation and interpretation. Always document assumptions and run sensitivity analyses.

#### Contact

Author & Maintenance: Minh Nguyen (minhnt@ump.edu.vn)
""",

        "a2_content_md": """
### Nguy√™n t·∫Øc

Ch·ª©c nƒÉng n√†y t√≠nh **c·ª° m·∫´u t·ªëi thi·ªÉu (n)** ƒë·ªÉ ∆∞·ªõc t√≠nh **t·ª∑ l·ªá bi·∫øn c·ªë / nguy c∆° n·ªÅn** (p) (prevalence) v·ªõi **ƒë·ªô ch√≠nh x√°c mong mu·ªën**, bi·ªÉu di·ªÖn b·∫±ng **n·ª≠a ƒë·ªô r·ªông kho·∫£ng tin c·∫≠y (KTC)** (margin of error).

·ª®ng d·ª•ng:
* m√¥ t·∫£ t·ª∑ l·ªá bi·∫øn c·ªë trong ƒëo√†n h·ªá v·ªõi KTC ƒë·ªß h·∫πp,
* l·∫≠p k·∫ø ho·∫°ch kh·∫£ thi v√† b√°o c√°o d·ªãch t·ªÖ,
* h·ªó tr·ª£ c√°c ph√¢n t√≠ch li√™n quan calibration.

**H·∫°n ch·∫ø:** Ph∆∞∆°ng ph√°p n√†y **kh√¥ng ƒë·∫£m b·∫£o** hi·ªáu nƒÉng m√¥ h√¨nh d·ª± b√°o (AUC, calibration slope, optimism). N√≥ ch·ªâ ƒë·∫£m b·∫£o ƒë·ªô ch√≠nh x√°c khi **∆∞·ªõc t√≠nh (p)**.

---

### Ch√∫ gi·∫£i c√°c gi√° tr·ªã ƒë·∫ßu v√†o

1. **T·ª∑ l·ªá bi·∫øn c·ªë** (p)
   T·ª∑ l·ªá k·∫øt c·ª•c x·∫£y ra d·ª± ki·∫øn trong qu·∫ßn th·ªÉ nghi√™n c·ª©u (v√≠ d·ª• 0,10).
   * N·∫øu ch∆∞a r√µ, n√™n nh·∫≠p m·ªôt **kho·∫£ng gi√° tr·ªã** v√† ch·∫°y ph√¢n t√≠ch ƒë·ªô nh·∫°y.
   * N·∫øu c·∫ßn ‚Äúb·∫£o th·ªß‚Äù cho b√†i to√°n ∆∞·ªõc t√≠nh t·ª∑ l·ªá, d√πng $p=0.50$ (ph∆∞∆°ng sai l·ªõn nh·∫•t).

2. **N·ª≠a ƒë·ªô r·ªông KTC m·ª•c ti√™u** (d)
   M·ª•c ti√™u sao cho KTC x·∫•p x·ªâ: $p \pm d$
   V√≠ d·ª•: $d = 0.01, 0.02, 0.03$ t∆∞∆°ng ·ª©ng ¬±1%, ¬±2%, ¬±3%.

3. **M·ª©c tin c·∫≠y** (1-$\\alpha$)
   Th∆∞·ªùng d√πng 0,95 ho·∫∑c 0,99.

4. **Ph∆∞∆°ng ph√°p t√≠nh KTC**
* **Wilson score (khuy·∫øn ngh·ªã):** ƒë·ªô bao ph·ªß t·ªët h∆°n Wald, nh·∫•t l√† khi (p) g·∫ßn 0 ho·∫∑c 1 ho·∫∑c c·ª° m·∫´u v·ª´a/nh·ªè.
* **Wald (x·∫•p x·ªâ chu·∫©n):** c√¥ng th·ª©c ƒë√≥ng ƒë∆°n gi·∫£n nh∆∞ng c√≥ th·ªÉ k√©m ch√≠nh x√°c khi (n) nh·ªè ho·∫∑c (p) c·ª±c tr·ªã.
* **Clopper‚ÄìPearson (exact):** b·∫£o th·ªß (KTC th∆∞·ªùng r·ªông h∆°n ‚Üí c·∫ßn (n) l·ªõn h∆°n).

---

### C√°ch t√≠nh (c√¥ng th·ª©c v√† √Ω t∆∞·ªüng)

Gi·∫£ s·ª≠ $X \sim \\text{Binomial}(n,p)$, $\hat p = X/n$. M·ª•c ti√™u l√† t√¨m (n) nh·ªè nh·∫•t sao cho:
$$ \\frac{\\text{Upper}(n) - \\text{Lower}(n)}{2} \le d $$

#### A) Wald (x·∫•p x·ªâ)
$$ n \\approx \\frac{z^2 p(1-p)}{d^2} $$

#### B) Wilson score (khuy·∫øn ngh·ªã)
S·ª≠ d·ª•ng c√¥ng th·ª©c kho·∫£ng tin c·∫≠y Wilson.

#### C) Clopper‚ÄìPearson (exact)
D√πng ph√¢n v·ªã Beta. ƒê√¢y l√† ph∆∞∆°ng ph√°p b·∫£o th·ªß.

---

### N√™n ch·ªçn gi√° tr·ªã bao nhi√™u theo th√¥ng l·ªá?

* **M·ª©c tin c·∫≠y:** 95% l√† chu·∫©n.
* **N·ª≠a ƒë·ªô r·ªông (d):** ¬±0,01 ƒë·∫øn ¬±0,03 (1%‚Äì3%) l√† m·ª©c hay g·∫∑p.
* **Ph∆∞∆°ng ph√°p:** Wilson l√† l·ª±a ch·ªçn m·∫∑c ƒë·ªãnh h·ª£p l√Ω.

### T√†i li·ªáu tham kh·∫£o quan tr·ªçng
1. **Wilson EB.** Probable inference... *JASA.* 1927.
2. **Newcombe RG.** Two-sided confidence intervals... *Stat Med.* 1998.
""",

        "b3_content_md": """
### M·ª•c ƒë√≠ch (ph∆∞∆°ng ph√°p n√†y l√† g√¨)

Ch·ª©c nƒÉng n√†y ∆∞·ªõc t√≠nh **c·ª° m·∫´u t·ªëi thi·ªÉu** ƒë·ªÉ ph√°t hi·ªán m·ªëi li√™n quan gi·ªØa bi·∫øn d·ª± b√°o (X) v√† **k·∫øt c·ª•c nh·ªã ph√¢n** (Y) b·∫±ng **h·ªìi quy logistic**, v·ªõi **OR m·ª•c ti√™u**, **($\\alpha$) hai ph√≠a**, v√† **power** ƒë√£ ch·ªçn.

ƒê√¢y l√† ph∆∞∆°ng ph√°p **power cho nghi√™n c·ª©u y·∫øu t·ªë ti√™n l∆∞·ª£ng / ki·ªÉm ƒë·ªãnh li√™n quan** (ki·ªÉm ƒë·ªãnh h·ªá s·ªë h·ªìi quy), **kh√¥ng ph·∫£i** ph∆∞∆°ng ph√°p ƒë·∫£m b·∫£o hi·ªáu nƒÉng c·ªßa **m√¥ h√¨nh d·ª± b√°o**. N√≥ **kh√¥ng ƒë·∫£m b·∫£o** calibration/discrimination c·ªßa m√¥ h√¨nh ƒëa bi·∫øn.

---

### Khi n√†o n√™n d√πng

D√πng B3 khi:

* B·∫°n c·∫ßn power ƒë·ªÉ ph√°t hi·ªán **OR c√≥ √Ω nghƒ©a l√¢m s√†ng** cho **m·ªôt bi·∫øn** (nh·ªã ph√¢n ho·∫∑c li√™n t·ª•c) trong logistic regression.
* M·ª•c ti√™u l√† **ki·ªÉm ƒë·ªãnh gi·∫£ thuy·∫øt** (bi·∫øn c√≥ li√™n quan k·∫øt c·ª•c hay kh√¥ng), kh√¥ng ph·∫£i x√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o nguy c∆°.

### Khi n√†o kh√¥ng n√™n d√πng

Kh√¥ng d√πng B3 l√†m ph∆∞∆°ng ph√°p ch√≠nh khi:

* M·ª•c ti√™u l√† **x√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o** (n√™n d√πng Riley/pmsampsize ho·∫∑c m√¥ ph·ªèng/assurance).
* B·∫°n d·ª± ƒë·ªãnh **ch·ªçn bi·∫øn theo d·ªØ li·ªáu**, d√πng nhi·ªÅu spline/t∆∞∆°ng t√°c, ho·∫∑c tuning m√¥ h√¨nh ph·ª©c t·∫°p (power cho 1 h·ªá s·ªë kh√¥ng c√≤n l√† m·ª•c ti√™u ph√π h·ª£p).
* D·ªØ li·ªáu c√≥ **ph·ª• thu·ªôc/c·ª•m** (ƒëa trung t√¢m/khoa/ph√≤ng) m√† ch∆∞a t√≠nh design effect.
* Thi·∫øt k·∫ø **case‚Äìcontrol** v·ªõi s·ªë ca/ch·ª©ng c·ªë ƒë·ªãnh (gi√° tr·ªã ($p_0$) kh√¥ng ph·∫£n √°nh nguy c∆° n·ªÅn qu·∫ßn th·ªÉ).

---

## M√¥ h√¨nh v√† tham s·ªë

M√¥ h√¨nh logistic:
$$
\\text{logit}{P(Y=1\\mid X)}=\\beta_0+\\beta_1 X
$$

* N·∫øu ($X$) nh·ªã ph√¢n 0/1:
  $$
  \\mathrm{OR}=\\exp(\\beta_1)
  $$
* N·∫øu ($X$) li√™n t·ª•c: OR ph·∫£i g·∫Øn v·ªõi m·ªôt m·ª©c thay ƒë·ªïi c·ªßa ($X$) (th√¥ng d·ª•ng nh·∫•t: **tƒÉng 1 SD**).

Ki·ªÉm ƒë·ªãnh:
$$
H_0:\\beta_1=0 \\quad \\text{vs}\\quad H_1:\\beta_1\\neq 0
$$

---

## Ch√∫ gi·∫£i c√°c ƒë·∫ßu v√†o

1. **Alpha (2 ph√≠a)** ($\\alpha$): th∆∞·ªùng 0,05; 0,01 n·∫øu nghi√™m ng·∫∑t h∆°n.
2. **Power** ($1-\\beta$): th∆∞·ªùng 0,80; 0,90 n·∫øu c·∫ßn th·∫≠n tr·ªçng.
3. **T·ª∑ l·ªá bi·∫øn c·ªë n·ªÅn** ($p_0$)

   * V·ªõi ($X$) nh·ªã ph√¢n: ($p_0=P(Y=1\\mid X=0)$).
   * V·ªõi ($X$) li√™n t·ª•c: ($p_0$) th∆∞·ªùng hi·ªÉu l√† t·ª∑ l·ªá bi·∫øn c·ªë t·∫°i **gi√° tr·ªã trung b√¨nh** c·ªßa ($X$) (sau khi center).
4. **OR m·ª•c ti√™u**: m·ª©c OR nh·ªè nh·∫•t c√≥ √Ω nghƒ©a l√¢m s√†ng.
5. **Lo·∫°i bi·∫øn d·ª± b√°o**

   * Nh·ªã ph√¢n: c·∫ßn ($q=P(X=1)$).
   * Li√™n t·ª•c: c·∫ßn OR cho **tƒÉng 1 SD** (ho·∫∑c ph·∫£i quy ƒë·ªïi t·ª´ OR theo 1 ƒë∆°n v·ªã).
6. **($R^2$) v·ªõi c√°c ƒë·ªìng bi·∫øn kh√°c**

   * ($R^2$) l√† m·ª©c ƒë·ªô ($X$) ƒë∆∞·ª£c gi·∫£i th√≠ch b·ªüi c√°c ƒë·ªìng bi·∫øn kh√°c (khi h·ªìi quy ($X$) theo c√°c bi·∫øn kh√°c).
   * ($R^2$) c√†ng l·ªõn ‚Üí c·∫ßn c·ª° m·∫´u c√†ng l·ªõn (v√¨ th√¥ng tin ‚Äúƒë·ªôc l·∫≠p‚Äù c·ªßa ($X$) gi·∫£m).

---

# C√°ch t√≠nh (c√¥ng th·ª©c)

## B∆∞·ªõc 1 ‚Äî Quy ƒë·ªïi OR v√† ($p_0$) sang ($p_1$) (khi ($X$) nh·ªã ph√¢n)

$$
\\text{odds}_0=\\frac{p_0}{1-p_0},\\quad \\text{odds}_1=\\mathrm{OR}\\cdot \\text{odds}_0,\\quad
p_1=\\frac{\\text{odds}_1}{1+\\text{odds}_1}
$$

T·ª∑ l·ªá bi·∫øn c·ªë chung:
$$
p=(1-q)p_0+q p_1
$$

## B∆∞·ªõc 2 ‚Äî Z-score

$$
z_{\\alpha}=z_{1-\\alpha/2}, \\qquad z_{\\beta}=z_{1-\\beta}=z_{\\text{power}}
$$

## A) C·ª° m·∫´u v·ªõi bi·∫øn d·ª± b√°o nh·ªã ph√¢n

$$
n_0=
\\frac{
\\left[
z_{\\alpha}\\sqrt{\\frac{p(1-p)}{q(1-q)}}
+
z_{\\beta}\\sqrt{\\frac{p_1(1-p_1)}{q}+\\frac{p_0(1-p_0)}{1-q}}
\\right]^2
}
{(p_1-p_0)^2}
$$

### Hi·ªáu ch·ªânh khi c√≥ nhi·ªÅu ƒë·ªìng bi·∫øn (t∆∞∆°ng quan v·ªõi bi·∫øn kh√°c)

$$
n=\\frac{n_0}{1-R^2}
$$

### S·ªë bi·∫øn c·ªë k·ª≥ v·ªçng

$$
E \\approx n\\cdot p
$$

---

## B) C·ª° m·∫´u v·ªõi bi·∫øn d·ª± b√°o li√™n t·ª•c

Gi·∫£ ƒë·ªãnh OR ƒë∆∞·ª£c ƒë·ªãnh nghƒ©a cho **tƒÉng 1 SD** c·ªßa ($X$) (k√Ω hi·ªáu ($\\mathrm{OR}_{SD}$)), v√† ($p_0$) l√† t·ª∑ l·ªá bi·∫øn c·ªë t·∫°i trung b√¨nh c·ªßa ($X$):

$$
n_0=\\frac{(z_{\\alpha}+z_{\\beta})^2}{p_0(1-p_0), [\\log(\\mathrm{OR}_{SD})]^2}
$$

N·∫øu OR nh·∫≠p theo **tƒÉng 1 ƒë∆°n v·ªã** l√† ($\\mathrm{OR}_{unit}$), v√† SD c·ªßa ($X$) l√† ($\\sigma_X$), th√¨:
$$
\\log(\\mathrm{OR}_{SD})=\\log(\\mathrm{OR}_{unit})\\cdot \\sigma_X
$$

Sau ƒë√≥ hi·ªáu ch·ªânh t∆∞∆°ng quan ƒë·ªìng bi·∫øn:
$$
n=\\frac{n_0}{1-R^2}
$$

---

## N√™n ch·ªçn gi√° tr·ªã bao nhi√™u theo th√¥ng l·ªá?

* **($\\alpha$)**: 0,05 (hai ph√≠a) l√† ph·ªï bi·∫øn; gi·∫£m ($\\alpha$) n·∫øu c√≥ nhi·ªÅu ki·ªÉm ƒë·ªãnh.
* **Power**: 0,80 (th∆∞·ªùng d√πng); 0,90 (th·∫≠n tr·ªçng h∆°n).
* **OR m·ª•c ti√™u**: ch·ªçn OR nh·ªè nh·∫•t c√≥ √Ω nghƒ©a l√¢m s√†ng (th∆∞·ªùng 1,2‚Äì2,0 t√πy b·ªëi c·∫£nh).
* **($p_0$)**: ∆∞u ti√™n d·ªØ li·ªáu b·ªánh vi·ªán; n·∫øu ch∆∞a c√≥, d√πng y vƒÉn v√† ch·∫°y ƒë·ªô nh·∫°y.
* **($q$)**: l·∫•y t·ª´ t·ª∑ l·ªá ph∆°i nhi·ªÖm th·ª±c t·∫ø; ($q$) g·∫ßn 0,5 th∆∞·ªùng cho c·ª° m·∫´u nh·ªè h∆°n; ($q$) r·∫•t th·∫•p/cao l√†m tƒÉng ($n$).
* **($R^2$)**: n·∫øu ch∆∞a ch·∫Øc, ch·∫°y ƒë·ªô nh·∫°y (0; 0,1; 0,25; 0,5).
* **Bi·∫øn li√™n t·ª•c**: n√™n chu·∫©n h√≥a ($X$) (mean 0, SD 1) ƒë·ªÉ OR theo 1 SD d·ªÖ hi·ªÉu.

---

## T√†i li·ªáu tham kh·∫£o quan tr·ªçng (2‚Äì5)

1. Hsieh FY, Bloch DA, Larsen MD. *A simple method of sample size calculation for linear and logistic regression.* Statistics in Medicine. 1998;17(14):1623‚Äì1634.
2. Hsieh FY. *Sample size tables for logistic regression.* Statistics in Medicine. 1989;8(7):795‚Äì802.
3. Whittemore AS. *Sample size for logistic regression with small response probability.* Journal of the American Statistical Association. 1981;76:27‚Äì32.
""",
        "c5_content_md": """
### Ph∆∞∆°ng ph√°p n√†y l√† g√¨?

C5 tri·ªÉn khai c√°c **ti√™u ch√≠ c·ª° m·∫´u t·ªëi thi·ªÉu c·ªßa Riley v√† c·ªông s·ª±** cho **x√¢y d·ª±ng m√¥ h√¨nh d·ª± b√°o ƒëa bi·∫øn** v·ªõi **k·∫øt c·ª•c nh·ªã ph√¢n** (h·ªìi quy logistic). M·ª•c ti√™u l√† b·∫£o ƒë·∫£m c·ª° m·∫´u ƒë·ªß ƒë·ªÉ:

1. **H·∫°n ch·∫ø overfitting** (nh·∫Øm t·ªõi h·ªá s·ªë co r√∫t to√†n c·ª•c / calibration slope m·ª•c ti√™u),
2. B·∫£o ƒë·∫£m **ƒë·ªô ch√≠nh x√°c** c·ªßa hi·ªáu nƒÉng m√¥ h√¨nh (gi·ªõi h·∫°n m·ª©c ‚Äúl·∫°c quan‚Äù c·ªßa $R^2$), v√†
3. ∆Ø·ªõc t√≠nh **nguy c∆° n·ªÅn/t·ª∑ l·ªá bi·∫øn c·ªë chung** (intercept) ƒë·ªß ch√≠nh x√°c.

ƒê√¢y l√† ph∆∞∆°ng ph√°p cho **ph√°t tri·ªÉn m√¥ h√¨nh** (kh√¥ng ph·∫£i ngo·∫°i ki·ªÉm). ƒê·∫∑c bi·ªát ph√π h·ª£p khi b·∫°n x√¢y d·ª±ng m√¥ h√¨nh logistic v·ªõi **danh s√°ch bi·∫øn v√† c√°ch m√£ h√≥a ƒë∆∞·ª£c x√°c ƒë·ªãnh tr∆∞·ªõc**, v√† mu·ªën thay th·∫ø quy t·∫Øc EPV ƒë∆°n gi·∫£n b·∫±ng ph∆∞∆°ng ph√°p c√≥ c∆° s·ªü h∆°n.

---

### Khi n√†o n√™n d√πng

D√πng C5 khi:

* B·∫°n ƒëang **x√¢y d·ª±ng** m√¥ h√¨nh d·ª± b√°o cho **k·∫øt c·ª•c nh·ªã ph√¢n**.
* B·∫°n c√≥ th·ªÉ ∆∞·ªõc l∆∞·ª£ng (d√π g·∫ßn ƒë√∫ng) **t·ª∑ l·ªá bi·∫øn c·ªë** v√† **hi·ªáu nƒÉng d·ª± ki·∫øn** (Cox‚ÄìSnell $R^2$ ho·∫∑c AUC).
* B·∫°n mu·ªën nh·∫Øm t·ªõi **√≠t overfitting** (v√≠ d·ª• $S \\ge 0{,}90$) v√† ƒë·ªô ch√≠nh x√°c h·ª£p l√Ω.

### Khi n√†o kh√¥ng n√™n d√πng (ho·∫∑c c·∫ßn th·∫≠n tr·ªçng)

Kh√¥ng n√™n ch·ªâ d·ª±a v√†o C5 khi:

* B·∫°n d·ª± ƒë·ªãnh **ch·ªçn bi·∫øn theo d·ªØ li·ªáu**, d√πng nhi·ªÅu t∆∞∆°ng t√°c/spline/tinh ch·ªânh ph·ª©c t·∫°p m√† ch∆∞a quy ƒë·ªïi ƒë√∫ng **df hi·ªáu d·ª•ng**.
* D·ªØ li·ªáu c√≥ **c·ª•m/ƒëa trung t√¢m** m√† ch∆∞a t√≠nh design effect.
* Ph∆∞∆°ng ph√°p m√¥ h√¨nh h√≥a kh√°c xa logistic chu·∫©n (ML ph·ª©c t·∫°p) m√† kh√¥ng c√≥ c√°ch quy ƒë·ªïi ƒë·ªô ph·ª©c t·∫°p sang **df hi·ªáu d·ª•ng**; khi ƒë√≥ n√™n c√¢n nh·∫Øc m√¥ ph·ªèng.
* B·∫°n kh√¥ng th·ªÉ bi·ªán minh b·∫•t k·ª≥ gi·∫£ ƒë·ªãnh n√†o v·ªÅ AUC/$R^2$; khi ƒë√≥ n√™n ch·∫°y ƒë·ªô nh·∫°y r·ªông v√†/ho·∫∑c d√πng m√¥ ph·ªèng.

---

## Ch√∫ gi·∫£i c√°c ƒë·∫ßu v√†o

1. **T·ª∑ l·ªá bi·∫øn c·ªë** (p)
   T·ª∑ l·ªá (Y=1) d·ª± ki·∫øn trong b·ªô d·ªØ li·ªáu ph√°t tri·ªÉn m√¥ h√¨nh.

2. **S·ªë tham s·ªë m√¥ h√¨nh (df)** (P)
   T·ªïng b·∫≠c t·ª± do c·ªßa t·∫•t c·∫£ bi·∫øn d·ª± b√°o **kh√¥ng t√≠nh intercept**.
   Bao g·ªìm: dummy c·ªßa bi·∫øn ph√¢n lo·∫°i, basis spline, t∆∞∆°ng t√°c, v√† m·ªçi bi·∫øn ƒë·ªïi t·∫°o th√™m h·ªá s·ªë.

3. **Hi·ªáu nƒÉng d·ª± ki·∫øn** (ch·ªçn m·ªôt)

* **Cox‚ÄìSnell ($R^2_{CS}$)**: ∆∞u ti√™n n·∫øu c√≥ t·ª´ nghi√™n c·ª©u li√™n quan (l√Ω t∆∞·ªüng l√† ƒë√£ hi·ªáu ch·ªânh l·∫°c quan).
* **AUC (C-statistic)**: n·∫øu kh√¥ng c√≥ $R^2_{CS}$, c√≥ th·ªÉ x·∫•p x·ªâ $R^2_{CS}$ t·ª´ AUC v√† ($p$) theo ph∆∞∆°ng ph√°p ƒë√£ c√¥ng b·ªë.
* **B·∫£o th·ªß (15% c·ªßa $R^2$ t·ªëi ƒëa)**: d√πng khi kh√¥ng c√≥ AUC/$R^2$; ch·ªâ n√™n d√πng cho ∆∞·ªõc t√≠nh s∆° b·ªô v√† lu√¥n ch·∫°y ph√¢n t√≠ch ƒë·ªô nh·∫°y.

4. **M·ª•c ti√™u shrinkage to√†n c·ª•c** (S)
   Th∆∞·ªõc ƒëo ki·ªÉm so√°t overfitting (th∆∞·ªùng di·ªÖn gi·∫£i g·∫ßn v·ªõi calibration slope k·ª≥ v·ªçng sau n·ªôi ki·ªÉm).

* M·∫∑c ƒë·ªãnh hay d√πng: $S=0{,}90$ (t∆∞∆°ng ƒë∆∞∆°ng c·∫ßn shrink ~10%).
* B·∫£o th·ªß h∆°n: $S=0{,}95$.

---

## Kh√°i ni·ªám v√† c√¥ng th·ª©c

### Cox‚ÄìSnell ($R^2$) v√† gi√° tr·ªã t·ªëi ƒëa

$$
R^2_{CS} = 1-\\exp\\left(\\frac{2}{n}(\\ell_0-\\ell_1)\\right),
$$
trong ƒë√≥ $\\ell_0$ l√† log-likelihood m√¥ h√¨nh ch·ªâ c√≥ intercept v√† $\\ell_1$ l√† log-likelihood m√¥ h√¨nh ƒë·∫ßy ƒë·ªß.

V·ªõi k·∫øt c·ª•c nh·ªã ph√¢n, $R^2_{CS}$ kh√¥ng ƒë·∫°t 1. Gi√° tr·ªã t·ªëi ƒëa ph·ª• thu·ªôc ($p$):
$$
\\ell_0 = n\\Big[p\\ln(p) + (1-p)\\ln(1-p)\\Big],
$$
$$
R^2_{CS,\\max}=1-\\exp\\left(\\frac{2\\ell_0}{n}\\right)
=1-\\exp\\Big(2[p\\ln(p) + (1-p)\\ln(1-p)]\\Big).
$$

Nagelkerke ($R^2$):
$$
R^2_{Nag}=\\frac{R^2_{CS}}{R^2_{CS,\\max}}.
$$

---

## Ba ti√™u ch√≠ Riley (k·∫øt c·ª•c nh·ªã ph√¢n)

### Ti√™u ch√≠ 1 ‚Äî Gi·ªõi h·∫°n overfitting b·∫±ng shrinkage m·ª•c ti√™u (S)

$$
n_1=\\left\\lceil
\\frac{P}{(S-1)\\ln\\left(1-\\frac{R^2_{CS}}{S}\\right)}
\\right\\rceil.
$$

### Ti√™u ch√≠ 2 ‚Äî Gi·ªõi h·∫°n m·ª©c l·∫°c quan c·ªßa ($R^2$) (m·∫∑c ƒë·ªãnh 0,05)

Ti√™u ch√≠ n√†y nh·∫Øm t·ªõi ch√™nh l·ªách tuy·ªát ƒë·ªëi (m·∫∑c ƒë·ªãnh $\\delta=0{,}05$) gi·ªØa ($R^2$) bi·ªÉu ki·∫øn v√† ($R^2$) hi·ªáu ch·ªânh tr√™n thang **Nagelkerke**. Shrinkage t∆∞∆°ng ·ª©ng:
$$
S_{\\delta}=\\frac{R^2_{CS}}{R^2_{CS}+\\delta R^2_{CS,\\max}}.
$$
Sau ƒë√≥:
$$
n_2=\\left\\lceil
\\frac{P}{(S_{\\delta}-1)\\ln\\left(1-\\frac{R^2_{CS}}{S_{\\delta}}\\right)}
\\right\\rceil.
$$

### Ti√™u ch√≠ 3 ‚Äî ∆Ø·ªõc t√≠nh ch√≠nh x√°c nguy c∆° n·ªÅn (intercept)

Nh·∫Øm t·ªõi ∆∞·ªõc t√≠nh ($p$) trong kho·∫£ng ($\\pm d$) (m·∫∑c ƒë·ªãnh $d=0{,}05$ ·ªü m·ª©c 95%):
$$
n_3=\\left\\lceil
\\left(\\frac{z_{1-\\alpha/2}}{d}\\right)^2 p(1-p)
\\right\\rceil,
\\quad \\text{m·∫∑c ƒë·ªãnh } z_{0.975}=1.96,; d=0.05.
$$

### K·∫øt qu·∫£ cu·ªëi c√πng

$$
n_{\\min}=\\max(n_1,n_2,n_3),\\qquad
E = n_{\\min}p,\\qquad
EPP=\\frac{E}{P}.
$$

---

## G·ª£i √Ω ch·ªçn gi√° tr·ªã theo th√¥ng l·ªá

* **Shrinkage (S)**: th∆∞·ªùng ch·ªçn **0,90**; c√¢n nh·∫Øc **0,95** n·∫øu m√¥ h√¨nh ph·ª©c t·∫°p ho·∫∑c mu·ªën gi·∫£m overfitting m·∫°nh h∆°n.
* **$\\delta=0{,}05$** (Ti√™u ch√≠ 2): th∆∞·ªùng gi·ªØ m·∫∑c ƒë·ªãnh.
* **ƒê·ªô ch√≠nh x√°c intercept (d=0{,}05)**: m·∫∑c ƒë·ªãnh t∆∞∆°ng ·ª©ng ∆∞·ªõc t√≠nh nguy c∆° n·ªÅn trong ¬±5%. N·∫øu c·∫ßn ch√≠nh x√°c h∆°n (d nh·ªè h∆°n) th√¨ c·∫ßn (n) l·ªõn h∆°n.
* **$R^2_{CS}$ d·ª± ki·∫øn**:

  * ∆Øu ti√™n gi√° tr·ªã **ƒë√£ hi·ªáu ch·ªânh l·∫°c quan** t·ª´ nghi√™n c·ª©u ph√°t tri·ªÉn t∆∞∆°ng t·ª±, ho·∫∑c gi√° tr·ªã bi·ªÉu ki·∫øn t·ª´ ngo·∫°i ki·ªÉm.
  * N·∫øu ch·ªâ c√≥ AUC, d√πng ph∆∞∆°ng ph√°p x·∫•p x·ªâ AUC‚Üí$R^2_{CS}$ theo b√†i b√°o h∆∞·ªõng d·∫´n.
  * N·∫øu kh√¥ng c√≥ AUC/$R^2$, t√πy ch·ªçn **15% c·ªßa $R^2_{CS,\\max}$** ch·ªâ n√™n d√πng ƒë·ªÉ ∆∞·ªõc t√≠nh s∆° b·ªô v√† lu√¥n ch·∫°y ph√¢n t√≠ch ƒë·ªô nh·∫°y.

---

## T√†i li·ªáu tham kh·∫£o quan tr·ªçng (2‚Äì5)

1. Riley RD, Snell KIE, Ensor J, et al. *Minimum sample size required for developing a multivariable prediction model: PART II‚Äîbinary and time-to-event outcomes.* Statistics in Medicine. 2019.
2. Riley RD, Ensor J, Snell KIE, et al. *Calculating the sample size required for developing a clinical prediction model.* BMJ. 2020.
3. Riley RD, Van Calster B, Collins GS. *A note on estimating the Cox‚ÄìSnell ($R^2$) from a reported C statistic (AUROC) to inform sample size calculations for developing a prediction model with a binary outcome.* Statistics in Medicine. 2021.
4. Harrell FE Jr, Lee KL, Mark DB. *Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.* Statistics in Medicine. 1996.
""",
    },
    "KO": {
        "title": "ÏòàÌõÑ Ïó∞Íµ¨ ÌëúÎ≥∏ ÌÅ¨Í∏∞ ÎèÑÍµ¨",
        "sidebar_title": "ÏÑ§Ï†ï",
        "language": "Ïñ∏Ïñ¥ / Language",
        "mode": "Î∞©Î≤ï ÏÑ†ÌÉù",
        "mode_riley": "Î∞©Î≤ï 1: Riley Îì± (Î∂ÑÏÑùÏ†Å)",
        "mode_bayes": "Î∞©Î≤ï 2: Î≤†Ïù¥ÏßÄÏïà Î≥¥Ï¶ù (ÏãúÎÆ¨Î†àÏù¥ÏÖò)",
        "mode_single": "Îã®Ïùº ÏãúÎÇòÎ¶¨Ïò§",
        "mode_batch": "ÎØºÍ∞êÎèÑ Î∂ÑÏÑù (Î≤îÏúÑ)",
        "method1_tab": "Î∞©Î≤ï 1 (Riley)",
        "method2_tab": "Î∞©Î≤ï 2 (Bayesian)",
        "nav_title": "ÌÉêÏÉâ",
        "nav_intro": "ÏÜåÍ∞ú Î∞è Í≥µÏãù",
        "nav_calc": "ÌëúÎ≥∏ ÌÅ¨Í∏∞ Í≥ÑÏÇ∞Í∏∞",
        "intro_heading": "ÌôòÏòÅÌï©ÎãàÎã§",
        "intro_text": "Ïù¥ ÎèÑÍµ¨Îäî Ïù¥Î∂ÑÌòï Í≤∞Í≥ºÍ∞Ä ÏûàÎäî ÏûÑÏÉÅ ÏòàÏ∏° Î™®Îç∏ Í∞úÎ∞úÏóê ÌïÑÏöîÌïú ÏµúÏÜå ÌëúÎ≥∏ ÌÅ¨Í∏∞Î•º Í≥ÑÏÇ∞ÌïòÎäî Îç∞ ÎèÑÏõÄÏùÑ Ï§çÎãàÎã§.",
        "formula_heading": "ÏàòÌïôÏ†Å ÌîÑÎ†àÏûÑÏõåÌÅ¨ (Î∞©Î≤ï 1)",
        "formula_intro": "Î∞©Î≤ï 1ÏùÄ Riley Îì±Ïù¥ Ï†úÍ≥µÌïú ÌèêÏáÑÌòï ÏÜîÎ£®ÏÖòÏùÑ ÏÇ¨Ïö©ÌïòÍ≥†, Î∞©Î≤ï 2Îäî Î≤†Ïù¥ÏßÄÏïà MCMC ÏãúÎÆ¨Î†àÏù¥ÏÖòÏùÑ ÏÇ¨Ïö©Ìï©ÎãàÎã§.",
        "sens_guide_title": "üí° ÎØºÍ∞êÎèÑ Î∂ÑÏÑù(Î∞∞Ïπò Î™®Îìú) ÏÇ¨Ïö©Î≤ï",
        "sens_guide_text": """
        - **Î≤îÏúÑ**: `min-max` ÌòïÏãùÏúºÎ°ú ÏûÖÎ†• (Ïòà: `0.05-0.10`). Îã®Í≥ÑÍ∞Ä ÏûêÎèôÏúºÎ°ú ÏÉùÏÑ±Îê©ÎãàÎã§.
        - **ÌäπÏ†ï Í∞í**: ÏâºÌëúÎ°ú Íµ¨Î∂ÑÎêú Î™©Î°ù ÏûÖÎ†• (Ïòà: `0.05, 0.10, 0.15`).
        """,
        "detail_view": "ÏãúÎÇòÎ¶¨Ïò§Î≥Ñ ÏÉÅÏÑ∏ Í≥ÑÏÇ∞ Î≥¥Í∏∞",
        "footer_refs": "Ï∞∏Í≥†Î¨∏Ìóå: Riley et al. (2018, 2020), BayesAssurance.",
        "calc_btn": "Í≥ÑÏÇ∞ÌïòÍ∏∞",
        "results": "Í≤∞Í≥º",
        "sanity": "Í±¥Ï†ÑÏÑ± Ïã¨ÏÇ¨ (EPV Í∑úÏπô)",
        "download_csv": "CSV Îã§Ïö¥Î°úÎìú",
        "download_report": "Ï†ÑÏ≤¥ Î≥¥Í≥†ÏÑú Îã§Ïö¥Î°úÎìú",
        "error_p": "Ïú†Î≥ëÎ•†ÏùÄ 0Í≥º 1 ÏÇ¨Ïù¥Ïó¨Ïïº Ìï©ÎãàÎã§.",
        "error_auc": "AUCÎäî 0.5ÏôÄ 1 ÏÇ¨Ïù¥Ïó¨Ïïº Ìï©ÎãàÎã§.",
        "error_parse": "ÏûÖÎ†•ÏùÑ Íµ¨Î¨∏ Î∂ÑÏÑùÌï† Ïàò ÏóÜÏäµÎãàÎã§.",
        "riley_inputs": "ÏûÖÎ†• ÌååÎùºÎØ∏ÌÑ∞ (Riley)",
        "prevalence": "Í≤∞Í≥º Ïú†Î≥ëÎ•† (Ïù¥Î≤§Ìä∏ Î∞úÏÉùÎ•†)",
        "prevalence_help": "Ïù¥Î≤§Ìä∏Í∞Ä Î∞úÏÉùÌïú Ï∞∏Í∞ÄÏûêÏùò ÎπÑÏú® (0 < p < 1).",
        "parameters": "ÏòàÏ∏° Î≥ÄÏàò ÌååÎùºÎØ∏ÌÑ∞ Ïàò (df)",
        "parameters_help": "Ï¥ù ÏûêÏú†ÎèÑ (Ï†àÌé∏ Ï†úÏô∏).",
        "shrinkage": "Î™©Ìëú Í∏ÄÎ°úÎ≤å ÏàòÏ∂ï (S)",
        "shrinkage_help": "Ìù¨ÎßùÌïòÎäî ÏàòÏ∂ï Í≥ÑÏàò (Í∏∞Î≥∏Í∞í 0.9).",
        "perf_measure": "ÏòàÏÉÅ ÏÑ±Îä•",
        "perf_auc": "AUC (C-ÌÜµÍ≥ÑÎüâ)",
        "perf_r2": "Cox-Snell R-Ï†úÍ≥±",
        "perf_cons": "Î≥¥ÏàòÏ†Å Ï†êÏàò (ÏµúÎåÄ R2Ïùò 15%)",
        "bayes_inputs": "ÏãúÎÆ¨Î†àÏù¥ÏÖò ÏÑ§Ï†ï (Î≤†Ïù¥ÏßÄÏïà Î≥¥Ï¶ù)",
        "dgm_settings": "Îç∞Ïù¥ÌÑ∞ ÏÉùÏÑ± Îß§Ïª§ÎãàÏ¶ò",
        "sim_settings": "ÏãúÎÆ¨Î†àÏù¥ÏÖò Î∞è MCMC",
        "eval_settings": "ÌèâÍ∞Ä Í∏∞Ï§Ä",
        "n_candidates": "ÌõÑÎ≥¥ ÌëúÎ≥∏ ÌÅ¨Í∏∞ (ÏâºÌëúÎ°ú Íµ¨Î∂Ñ)",
        "n_candidates_help": "ÌÖåÏä§Ìä∏Ìï† N Í∞í Î™©Î°ù, Ïòà: 500, 1000, 1500.",
        "correlation": "ÏòàÏ∏° Î≥ÄÏàò ÏÉÅÍ¥ÄÍ¥ÄÍ≥Ñ (rho)",
        "n_sims": "NÎãπ ÏãúÎÆ¨Î†àÏù¥ÏÖò ÌöüÏàò",
        "assurance_threshold": "Î≥¥Ï¶ù ÏûÑÍ≥ÑÍ∞í (Î™©Ìëú ÌôïÎ•†)",
        "run_simulation": "Î≤†Ïù¥ÏßÄÏïà ÏãúÎÆ¨Î†àÏù¥ÏÖò Ïã§Ìñâ",
        "simulation_running": "ÏãúÎÆ¨Î†àÏù¥ÏÖò Ïã§Ìñâ Ï§ë... ÏãúÍ∞ÑÏù¥ Í±∏Î¶¥ Ïàò ÏûàÏäµÎãàÎã§.",
        "assurance_result": "Î≥¥Ï¶ù Î∂ÑÏÑù",
        "mode_dev_sim": "Î∞©Î≤ï 6: Í∞úÎ∞ú ÏãúÎÆ¨Î†àÏù¥ÏÖò (ÎπàÎèÑÏ£ºÏùò)",
        "method6_tab": "Î∞©Î≤ï 6 (ÏãúÎÆ¨Î†àÏù¥ÏÖò)",
        "dev_sim_intro": "Î™®Îç∏ Í∞úÎ∞úÏùÑ ÏúÑÌïú ÏãúÎÆ¨Î†àÏù¥ÏÖò Í∏∞Î∞ò ÌëúÎ≥∏ ÌÅ¨Í∏∞ (samplesizedevÏôÄ Ïú†ÏÇ¨Ìïú ÎπàÎèÑÏ£ºÏùò Ï†ëÍ∑ºÎ≤ï).",
        "dev_mode_simple": "Î™®Îìú A: Îã®Ïàú (AUC Í∏∞Î∞ò)",
        "dev_mode_custom": "Î™®Îìú B: ÏÇ¨Ïö©Ïûê Ï†ïÏùò DGM",
        "target_auc": "Î™©Ìëú ÌèâÍ∑† AUC (C-ÌÜµÍ≥ÑÎüâ)",
        "target_auc_help": "ÏïåÍ≥†Î¶¨Ï¶òÏù¥ Ïù¥ AUCÎ•º Îã¨ÏÑ±ÌïòÍ∏∞ ÏúÑÌïú Î≤†ÌÉÄ Í≥ÑÏàòÎ•º Ï∞æÏäµÎãàÎã§.",
        "criteria_settings": "ÏÑ±Îä• Í∏∞Ï§Ä (ÌÜµÍ≥º/Ïã§Ìå®)",
        "crit_slope_mean": "ÌèâÍ∑† ÍµêÏ†ï Í∏∞Ïö∏Í∏∞ >= 0.9",
        "crit_slope_ci": "Pr(0.9 <= Í∏∞Ïö∏Í∏∞ <= 1.1) >= 80%",
        "crit_auc": "ÌèâÍ∑† AUC >= Î™©Ìëú",
        "audit_trail": "RNG Í∞êÏÇ¨ Ï∂îÏ†Å (JSON)",
        "future_methods": "Ìñ•ÌõÑ Î≤ÑÏ†ÑÏóêÏÑú Ï†úÍ≥µ ÏòàÏ†ï...",
        "method_quick_tab": "A. Ïã†ÏÜç / Í∏∞Î≥∏",
        "quick_mode_epv": "A1: EPV / EPP Í∑úÏπô (Í≤ΩÌóòÏ†Å)",
        "quick_mode_risk": "A2: Í∏∞Î≥∏ ÏúÑÌóò Ï†ïÎ∞ÄÎèÑ (CI ÎÑàÎπÑ)",
        "target_epv": "Î™©Ìëú ÌååÎùºÎØ∏ÌÑ∞Îãπ Ïù¥Î≤§Ìä∏ Ïàò (EPP)",
        "target_epv_help": "ÏùºÎ∞òÏ†ÅÏù∏ Í≤ΩÌóòÏ†Å ÏàòÏπòÎäî 10, 15, 20ÏûÖÎãàÎã§. EPPÍ∞Ä EPVÎ≥¥Îã§ ÏÑ†Ìò∏Îê©ÎãàÎã§.",
        "epv_warning_title": "‚ö†Ô∏è Ï§ëÏöî Í≤ΩÍ≥†",
        "epv_warning_text": "EPV/EPPÎäî ÎåÄÎûµÏ†ÅÏù∏ Í≤ΩÌóòÏ†Å Í∑úÏπôÏûÖÎãàÎã§. ÍµêÏ†ï, ÌåêÎ≥ÑÏùÑ Î≥¥Ïû•ÌïòÍ±∞ÎÇò ÎÇôÍ¥ÄÏ£ºÏùòÎ•º Î∞©ÏßÄÌïòÏßÄ ÏïäÏäµÎãàÎã§. Î≥ÄÏàò ÏÑ†ÌÉù Î∞è ÎπÑÏÑ†Ìòï Ìï≠Ïóê ÎØºÍ∞êÌï©ÎãàÎã§.",
        "ci_level": "Ïã†Î¢∞ ÏàòÏ§Ä",
        "ci_half_width": "Î™©Ìëú Î∞ò-ÎÑàÎπÑ (Ïò§Ï∞® ÌïúÍ≥Ñ)",
        "ci_method": "CI Î∞©Î≤ï",
        "ci_method_wilson": "Wilson Score (Í∂åÏû•)",
        "ci_method_wald": "Wald (Îã®Ïàú)",
        "ci_method_cp": "Clopper-Pearson (Î≥¥ÏàòÏ†Å)",
        "risk_help": "ÌäπÏ†ï Ï†ïÎ∞ÄÎèÑÎ°ú Ïù¥Î≤§Ìä∏ Î∞úÏÉùÎ•† pÎ•º Ï∂îÏ†ïÌïòÍ∏∞ ÏúÑÌïú NÏùÑ Í≥ÑÏÇ∞Ìï©ÎãàÎã§. ÏòàÏ∏° Î™®Îç∏ ÏÑ±Îä•ÏùÑ Î≥¥Ïû•ÌïòÏßÄ ÏïäÏäµÎãàÎã§.",
        "title_b3": "B3: Î°úÏßÄÏä§Ìã± Í≤ÄÏ†ïÎ†• (Hsieh)",
        "title_b4": "B4: Cox Í≤ÄÏ†ïÎ†• (Schoenfeld)",
        "interpretation": "Í≤∞Í≥º Ìï¥ÏÑù",
        "d8_assumptions": "**Í∞ÄÏ†ï**: Hanley & McNeil (1982) Î∂ÑÏÇ∞ Í∑ºÏÇ¨ÏπòÎ•º ÏÇ¨Ïö©Ìï©ÎãàÎã§. AUCÏóê ÎåÄÌï¥ ÎåÄÏπ≠Ï†Å Ï†ïÍ∑ú Î∂ÑÌè¨Î•º Í∞ÄÏ†ïÌï©ÎãàÎã§.",
        "d8_mode_n_to_width": "NÏúºÎ°úÎ∂ÄÌÑ∞ CI ÎÑàÎπÑ Í≥ÑÏÇ∞",
        "d8_mode_width_to_n": "CI ÎÑàÎπÑÎ°úÎ∂ÄÌÑ∞ ÌïÑÏöîÌïú N Í≥ÑÏÇ∞",
        "d8_opt_settings": "Í≥†Í∏â ÏµúÏ†ÅÌôî ÏÑ§Ï†ï",
        "d8_practical_rounding": "Ïã§Ïö©Ï†ÅÏù∏ Ï†ïÏàò Î∞òÏò¨Î¶º ÌëúÏãú",
        "d8_n_input": "ÌëúÎ≥∏ ÌÅ¨Í∏∞ (N)",
        "d8_width_input": "CI ÎÑàÎπÑ (Ìï©Í≥Ñ)",
        "d8_opt_bound": "ÌÉêÏÉâ ÏÉÅÌïúÏÑ†",
        "d8_opt_tol": "ÌóàÏö© Ïò§Ï∞®",
        "title_d8": "D8: AUC Ï†ïÎ∞ÄÎèÑ (Hanley-McNeil)",
        "d8_desc": "Ìù¨ÎßùÌïòÎäî Ï†ïÎ∞ÄÎèÑ(CI ÎÑàÎπÑ)Î°ú AUCÎ•º Ï∂îÏ†ïÌïòÍ∏∞ ÏúÑÌïú ÌëúÎ≥∏ ÌÅ¨Í∏∞Î•º Í≥ÑÏÇ∞Ìï©ÎãàÎã§.",
        "auc_expected": "ÏòàÏÉÅ AUC (C-ÌÜµÍ≥ÑÎüâ)",
        "formulas_header": "üìö Í≥µÏãù Î∞è Í∏∞Ïà†Ï†Å ÏÑ∏Î∂Ä ÏÇ¨Ìï≠",
        "title_d9": "D9: Ïô∏Î∂Ä Í≤ÄÏ¶ù (ÎßûÏ∂§Ìòï)",
        "common_inputs": "Í≥µÌÜµ ÌååÎùºÎØ∏ÌÑ∞",
        "search_placeholder": "Î∞©Î≤ï Í≤ÄÏÉâ...",
        "settings": "ÏÑ§Ï†ï",
        "footer_copyright": "¬© 2026 Prognostic Research Sample Size Tool. ÌïôÏà†/Ïó∞Íµ¨Ïö© Ï†ÑÏö©.",
        "footer_author": "Ï†ÄÏûê Î∞è Ïú†ÏßÄÍ¥ÄÎ¶¨: Minh Nguyen (minhnt@ump.edu.vn)",
        "footer_disclaimer": "Î©¥Ï±Ö Ï°∞Ìï≠: ÏûÑÏÉÅÏ†Å Î≥¥Ï¶ù ÏóÜÏùå. ÏÇ¨Ïö©ÏûêÎäî Í≤∞Í≥º Í≤ÄÏ¶ù Î∞è Ìï¥ÏÑùÏóê ÎåÄÌïú Ï±ÖÏûÑÏù¥ ÏûàÏäµÎãàÎã§.",

        "intro_complete_md": """
### Welcome

This app helps clinicians and researchers plan minimum sample size for prognostic research, including:
* Prognostic factor studies (power to detect associations),
* Clinical prediction model development (risk prediction), and
* Model validation / updating (external validation, recalibration).

It is designed for binary outcomes (e.g., event vs no event) and, for some modules, time-to-event outcomes (Cox PH).

Source code (download): [https://gitlab.com/minhthiennguyen/pmsample/](https://gitlab.com/minhthiennguyen/pmsample/)

### Getting started (for new users)

#### 1. Clarify your study goal
* Are you testing a single prognostic factor (association)?
* Are you building a prediction model?
* Are you validating an existing model in a new population?

#### 2. Estimate the event rate $p$ (or event fraction for survival)
* Prefer local hospital data (best).
* If uncertain, enter a range and run a sensitivity analysis.

#### 3. Count model complexity correctly (parameters / df)
Use parameters (degrees of freedom), not just "number of variables."
* Binary predictor: 1 df
* Categorical with $L$ levels: $L-1$ df
* Spline (RCS with $K$ knots): $K-1$ df
* Interaction: $df(A \\times B) = df(A) \\cdot df(B)$

#### 4. Choose a method from the catalog below
* Use **"Quick tools"** for rough planning only.
* Use **Riley / simulation / assurance** when you are developing a prediction model.

---

### When to use this app (and when not to)

**Use this app when you are:**
* Planning retrospective or prospective cohort studies in prognosis/prediction
* Developing or validating risk prediction models
* Estimating sample size for precision (CI width) of prevalence or AUC
* Designing external validation with calibration and discrimination targets

**Do NOT use this app as the primary tool when you are:**
* Designing randomized controlled trials (use RCT-specific power/sample size methods)
* Planning diagnostic accuracy studies for sensitivity/specificity without prediction modeling
* Expecting a single "correct" number: sample size planning requires assumptions and should include sensitivity analyses

---

### Available Methods (Overview)

#### A. Quick / Basic (fast, approximate)

**A1 ‚Äî Rules of Thumb (EPV/EPP) (heuristic)**
* **Use when:** you need a quick sanity check on whether events are "roughly sufficient" for a planned model size.
* **Do not use when:** model includes splines/interactions/variable selection, or event rate is low‚ÄîEPV/EPP does not guarantee good calibration or low optimism.
* **Key inputs:** event rate $p$, number of parameters $P$ (df), target EPP (e.g., 10/15/20)
* **Core output:** required events $E=t \\cdot P$, required sample size $N=\\lceil E/p \\rceil$
* **Strengths:** extremely simple; good for early feasibility
* **Weaknesses:** can be misleading; not performance-based

**A2 ‚Äî Baseline Risk Precision (CI width for prevalence)**
* **Use when:** your goal is to estimate the event rate $p$ with a desired CI half-width (e.g., ¬±2%).
* **Do not use when:** you want prediction model performance guarantees (AUC/calibration slope).
* **Key inputs:** expected $p$, CI method (Wilson recommended), confidence level, target half-width $d$
* **Core output:** minimum $N$ such that CI half-width $\\le d$
* **Strengths:** direct precision target; transparent assumptions
* **Weaknesses:** about prevalence only, not model performance

#### B. Prognostic factor (power) (association-focused, not prediction model sizing)

**B3 ‚Äî Logistic OR Power (Hsieh)**
* **Use when:** you want power to detect a target odds ratio (OR) for a prognostic factor in logistic regression.
* **Do not use when:** your primary goal is prediction model development (calibration/discrimination), not hypothesis testing.
* **Key inputs:** baseline risk $p_0$, target OR, alpha, power, exposure prevalence (binary) or SD (continuous), optional $R^2$ with covariates
* **Core output:** required $N$ (and implied events) to detect the OR
* **Strengths:** classic power framework for association
* **Weaknesses:** does not address prediction model performance; sensitive to input assumptions

**B4 ‚Äî Cox HR Power (Schoenfeld)**
* **Use when:** time-to-event outcome; you want power to detect a hazard ratio (HR) under Cox PH.
* **Do not use when:** PH assumption likely violated, or event fraction is highly uncertain and cannot be reasonably estimated.
* **Key inputs:** HR, alpha, power, allocation proportion (binary) or SD (continuous), expected event fraction during follow-up
* **Core output:** required number of events; convert to $N$ using event fraction
* **Strengths:** widely accepted; event-based planning is intuitive
* **Weaknesses:** depends strongly on event fraction and follow-up/censoring assumptions

#### C. Prediction model development (recommended for risk model building)

**C5 ‚Äî Riley et al. (Analytical; pmsampsize-like)**
* **Use when:** developing a multivariable prediction model; you want to control overfitting and ensure adequate precision.
* **Do not use when:** you cannot provide reasonable assumptions for prevalence and anticipated model performance (AUC or $R^2$); in that case, use sensitivity analysis or simulation.
* **Key inputs:** event rate $p$, parameters $P$ (df), target shrinkage (e.g., 0.90), anticipated model performance (AUC or Cox‚ÄìSnell $R^2$)
* **Core output:** minimum $N$ meeting multiple criteria (overfitting control + precision)
* **Strengths:** principled, performance-aware, widely cited
* **Weaknesses:** depends on performance assumptions; requires careful df counting

**C6 ‚Äî Development Simulation (Frequentist; samplesizedev/custom DGM)**
* **Use when:** you prefer "simulate what you will do," especially with nonlinearity/interactions and custom data structures.
* **Do not use when:** you cannot specify a plausible data-generating mechanism (DGM) or you need results instantly (compute-intensive).
* **Key inputs:** candidate $N$ grid, DGM assumptions (predictor distributions/correlations/effects), performance targets (e.g., calibration slope range, AUC threshold), simulation replicates, seed
* **Core output:** smallest $N$ achieving targets with acceptable probability/precision
* **Strengths:** flexible; aligns with complex modeling
* **Weaknesses:** assumptions-heavy; computational cost

**C7 ‚Äî Bayesian Assurance (MCMC)**
* **Use when:** the final model will be estimated with Bayesian MCMC, and you want sample size based on assurance (probability of meeting posterior performance/precision targets).
* **Do not use when:** priors cannot be justified or computation budget is limited.
* **Key inputs:** DGM, priors, candidate $N$, MCMC settings, assurance threshold (e.g., 80%/90%), performance/precision targets
* **Core output:** minimal $N$ meeting assurance threshold
* **Strengths:** coherent for Bayesian workflows; directly targets posterior criteria
* **Weaknesses:** computationally intensive; requires prior specification

#### D. Validation / Updating (for existing models)

**D8 ‚Äî AUC Precision (Hanley‚ÄìMcNeil / presize)**
* **Use when:** your validation goal is precision of AUC (CI width).
* **Do not use when:** calibration (slope/CITL) is the primary concern‚Äîthis method targets AUC only.
* **Key inputs:** expected AUC, prevalence or case-control ratio, confidence level, target CI width
* **Core output:** minimum $N$ to achieve desired AUC CI width
* **Strengths:** simple; quick planning for discrimination precision
* **Weaknesses:** approximate variance; ignores calibration

**D9 ‚Äî External Validation (Tailored; pmvalsampsize / sampsizeval)**
* **Use when:** you want validation sizing targeting multiple performance measures (calibration + discrimination), often requiring assumptions about the LP distribution.
* **Do not use when:** you cannot justify LP distribution assumptions or expected performance.
* **Key inputs:** prevalence, expected AUC, calibration slope/CITL targets, CI widths or SE targets, LP distribution assumptions
* **Core output:** recommended $N$ meeting precision criteria across measures
* **Strengths:** tailored; calibration-aware
* **Weaknesses:** requires additional assumptions; more complex

**D10 ‚Äî External Validation (Simulation; LP-based)**
* **Use when:** you can specify/estimate the distribution of the linear predictor (LP) in the target validation population and want simulation-based precision planning.
* **Do not use when:** LP distribution is unknown and cannot be approximated.
* **Key inputs:** LP distribution (normal/beta/empirical), miscalibration parameters, CI width targets for metrics, replicates, seed
* **Core output:** minimal $N$ achieving precision targets under simulation
* **Strengths:** very flexible; matches "simulate what you expect"
* **Weaknesses:** assumptions-heavy; computational cost

**D11 ‚Äî Updating / Recalibration (intercept/slope)**
* **Use when:** you will recalibrate an existing model (update intercept and/or slope) and need adequate precision.
* **Do not use when:** you are developing a brand-new model (use C5‚ÄìC7).
* **Key inputs:** updating type (intercept only vs intercept+slope), event rate, precision targets
* **Core output:** $N$ sufficient for stable updating
* **Strengths:** practical for real-world deployment
* **Weaknesses:** depends on local case-mix and model transportability assumptions

---

#### disclaimer

No clinical warranty; users are responsible for validation and interpretation. Always document assumptions and run sensitivity analyses.

#### Contact

Author & Maintenance: Minh Nguyen (minhnt@ump.edu.vn)
""",

        "a2_content_md": """
### Ïù¥Í≤ÉÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå

Ïù¥ Î™®ÎìàÏùÄ **ÏõêÌïòÎäî Ï†ïÎ∞ÄÎèÑ**(Ïã†Î¢∞ Íµ¨Í∞Ñ(CI) Î∞òÌè≠ ÎòêÎäî Ïò§Ï∞® ÌïúÍ≥ÑÎ°ú ÌëúÌòÑÎê®)Î°ú **Í∏∞Î≥∏ ÏúÑÌóò / ÏÇ¨Í±¥ Î∞úÏÉùÎ•†**(p)(Ï¶â, Í≤∞Í≥ºÏùò Ïú†Î≥ëÎ•†)ÏùÑ Ï∂îÏ†ïÌïòÎäî Îç∞ ÌïÑÏöîÌïú **ÏµúÏÜå ÌëúÎ≥∏ ÌÅ¨Í∏∞(n)**Î•º Ï∂îÏ†ïÌï©ÎãàÎã§.

Îã§ÏùåÍ≥º Í∞ôÏùÄ Í≤ΩÏö∞Ïóê Ïú†Ïö©Ìï©ÎãàÎã§:
* ÏßÄÏ†ïÎêú Ï†ïÎ∞ÄÎèÑÎ°ú ÏΩîÌò∏Ìä∏ ÎÇ¥ Í≤∞Í≥º Ïú†Î≥ëÎ•† ÏÑ§Î™Ö,
* ÌÉÄÎãπÏÑ± Í≥ÑÌöç Î∞è Í∏∞Î≥∏ ÏúÑÌóò Î≥¥Í≥†,
* ÍµêÏ†ï Í¥ÄÎ†® Í≥ÑÌöç ÏßÄÏõê (Ïòà: calibration-in-the-largeÎäî ÏÇ¨Í±¥ Î∞úÏÉùÎ•†Ïóê ÏùòÏ°¥).

**Ï§ëÏöîÌïú Ï†úÌïú ÏÇ¨Ìï≠:** Ïù¥ Í≥ÑÏÇ∞ÏùÄ ÏòàÏ∏° Î™®Îç∏ ÏÑ±Îä•(AUC, ÍµêÏ†ï Í∏∞Ïö∏Í∏∞, ÎÇôÍ¥ÄÏ£ºÏùò)ÏùÑ **Î≥¥Ïû•ÌïòÏßÄ ÏïäÏäµÎãàÎã§**. Ïò§ÏßÅ (p) Ï∂îÏ†ïÏùò Ï†ïÎ∞ÄÎèÑÎßåÏùÑ Î™©ÌëúÎ°ú Ìï©ÎãàÎã§.

---

### ÏûÖÎ†• Í∞í (ÏùòÎØ∏)

1. **Í≤∞Í≥º Ïú†Î≥ëÎ•† / ÏÇ¨Í±¥ Î∞úÏÉùÎ•†** (p)
   ÎåÄÏÉÅ Î™®ÏßëÎã®ÏóêÏÑú ÏòàÏÉÅÎêòÎäî ÏÇ¨Í±¥ ÎπÑÏú® (Ïòà: 0.10).
   * Ïïå Ïàò ÏóÜÎäî Í≤ΩÏö∞, ÌÉÄÎãπÌïú Î≤îÏúÑÎ•º Í≥†Î†§ÌïòÏó¨ ÎØºÍ∞êÎèÑ Î∂ÑÏÑùÏùÑ Ïã§ÌñâÌïòÏã≠ÏãúÏò§.
   * Ïú†Î≥ëÎ•† Ï†ïÎ∞ÄÎèÑÏóê ÎåÄÌï¥ Î≥¥ÏàòÏ†ÅÏù∏ "ÏµúÏïÖÏùò Í≤ΩÏö∞"Î•º ÏõêÌïúÎã§Î©¥ (p=0.50)ÏùÑ ÏÇ¨Ïö©ÌïòÏã≠ÏãúÏò§ (Î∂ÑÏÇ∞ ÏµúÎåÄÌôî).

2. **Î™©Ìëú Î∞òÌè≠ (Ïò§Ï∞® ÌïúÍ≥Ñ)** (d)
   CIÍ∞Ä ÎåÄÎûµ Îã§ÏùåÍ≥º Í∞ôÎèÑÎ°ù ÌïòÎäî ÏõêÌïòÎäî Ï†ïÎ∞ÄÎèÑ:
   $p \pm d$
   Ïòà: (d = 0.01, 0.02, 0.03) (Ï¶â, ¬±1%, ¬±2%, ¬±3%).

3. **Ïã†Î¢∞ ÏàòÏ§Ä** (1-$\\alpha$)
   ÏùºÎ∞òÏ†ÅÏù∏ Í∞í: 0.95 ÎòêÎäî 0.99.

4. **CI Î∞©Î≤ï**
* **Wilson score (Í∂åÏû•):** WaldÎ≥¥Îã§ Ïª§Î≤ÑÎ¶¨ÏßÄÍ∞Ä Ï¢ãÏúºÎ©∞, ÌäπÌûà (p)Í∞Ä 0Ïù¥ÎÇò 1Ïóê Í∞ÄÍπùÍ±∞ÎÇò ÌëúÎ≥∏ ÌÅ¨Í∏∞Í∞Ä Ï†ÅÎãπÌï† Îïå Ï¢ãÏäµÎãàÎã§.
* **Wald (Ï†ïÍ∑ú Í∑ºÏÇ¨):** Í∞ÑÎã®Ìïú ÌèêÏáÑÌòïÏù¥ÏßÄÎßå (n)Ïù¥ ÏûëÍ±∞ÎÇò (p)Í∞Ä Í∑πÎã®Ï†ÅÏùº Îïå ÏÑ±Îä•Ïù¥ Îñ®Ïñ¥Ïßà Ïàò ÏûàÏäµÎãàÎã§.
* **Clopper‚ÄìPearson (Ï†ïÌôï):** Î≥¥ÏàòÏ†ÅÏûÖÎãàÎã§ (Ï¢ÖÏ¢Ö Îçî ÎÑìÏùÄ CIÎ•º ÏÇ∞Ï∂úÌïòÎØÄÎ°ú Îçî ÌÅ∞ (n)Ïù¥ ÌïÑÏöîÌï®).

---

### ÌïµÏã¨ Í≥ÑÏÇ∞ (ÏõêÎ¶¨)

$X \sim \\text{Binomial}(n,p)$, $\hat p = X/n$Ïù¥ÎùºÍ≥† Ìï©ÏãúÎã§. Î™©ÌëúÎäî ÏÑ†ÌÉùÌïú CI Î∞©Î≤ïÏù¥ Îã§ÏùåÏùÑ ÏÇ∞Ï∂úÌïòÎèÑÎ°ù ÌïòÎäî Í∞ÄÏû• ÏûëÏùÄ (n)ÏùÑ Ï∞æÎäî Í≤ÉÏûÖÎãàÎã§:
$$
\\frac{\\text{Upper}(n) - \\text{Lower}(n)}{2} \le d
$$

#### A) Wald (ÌèêÏáÑÌòï Í∑ºÏÇ¨)
$$ n \\approx \\frac{z^2 p(1-p)}{d^2} $$
**Ï∞∏Í≥†:** Îπ†Î•¥ÏßÄÎßå (n)Ïù¥ ÏûëÍ±∞ÎÇò (p)Í∞Ä Í∑πÎã®Ï†ÅÏùº ÎïåÎäî Í∂åÏû•ÎêòÏßÄ ÏïäÏäµÎãàÎã§.

#### B) Wilson score Íµ¨Í∞Ñ (Í∂åÏû•)
Wilson score Íµ¨Í∞Ñ Í≥µÏãùÏùÑ ÏÇ¨Ïö©Ìï©ÎãàÎã§.

#### C) Clopper‚ÄìPearson ‚ÄúÏ†ïÌôï‚Äù Íµ¨Í∞Ñ
Beta Î∂ÑÏúÑÏàòÎ•º ÏÇ¨Ïö©Ìï©ÎãàÎã§. Î≥¥ÏàòÏ†ÅÏù∏ Î∞©Î≤ïÏûÖÎãàÎã§.

---

### Ïã§Ïö©Ï†ÅÏù∏ Í∏∞Î≥∏Í∞í

* **Ïã†Î¢∞ ÏàòÏ§Ä:** 95%Í∞Ä ÌëúÏ§ÄÏûÖÎãàÎã§.
* **Î∞òÌè≠ (d):** ¬±0.01 ~ ¬±0.03 (1%‚Äì3%)Ïù¥ ÏùºÎ∞òÏ†ÅÏù∏ Î™©ÌëúÏûÖÎãàÎã§.
* **Î∞©Î≤ï:** WilsonÏù¥ Í∞ïÎ†•Ìïú Í∏∞Î≥∏Í∞íÏûÖÎãàÎã§.

### Ï£ºÏöî Ï∞∏Í≥† Î¨∏Ìóå
1. **Wilson EB.** Probable inference... *JASA.* 1927.
2. **Newcombe RG.** Two-sided confidence intervals... *Stat Med.* 1998.
""",

        "b3_content_md": """
### Purpose (what this method is)

This module estimates the **minimum sample size** needed to detect an association between a predictor (X) and a **binary outcome** (Y) using **logistic regression**, targeting a specified **odds ratio (OR)**, **two-sided ($\\alpha$)**, and **power**.

This is a **prognostic factor / association-focused** power calculation (testing a regression coefficient), **not** a prediction-model performance method. It does **not** guarantee good calibration or discrimination of a multivariable prediction model.

---

### When to use

Use B3 when:

* You want power to detect a **clinically meaningful OR** for a **single predictor** (binary or continuous) in logistic regression.
* Your primary goal is **hypothesis testing** (is the predictor associated with the outcome?), not building a risk prediction model.

### When NOT to use

Do not use B3 as your main approach when:

* Your goal is **prediction model development** (use Riley/pmsampsize or simulation/assurance methods).
* You plan **data-driven variable selection**, many interactions/splines, or complex machine-learning tuning (power for a single coefficient is not the right target).
* Data are **clustered** (multicenter/ward-level correlation) or strongly dependent without adjusting the design effect.
* You have a **case‚Äìcontrol** design with fixed case/control sampling (baseline risks ($p_0$) may not represent the source population).

---

## Statistical model and parameters

Logistic regression model:
$$
\\text{logit}{P(Y=1\\mid X)}=\\beta_0+\\beta_1 X
$$

* For **binary** ($X\\in\\{0,1\\}$):
  $$
  \\mathrm{OR}=\\exp(\\beta_1)
  $$
* For **continuous** ($X$): OR must be defined for a specific change in ($X$), commonly **1 SD increase**.

Hypothesis test:
$$
H_0:\\beta_1=0 \\quad \\text{vs}\\quad H_1:\\beta_1\\neq 0
$$

---

## Inputs (what each value means)

1. **Alpha (two-sided)** ($\\alpha$)
   Common choices: 0.05 (standard), 0.01 (more stringent).

2. **Power** ($1-\\beta$)
   Common choices: 0.80 (standard), 0.90 (more conservative).

3. **Baseline event rate** ($p_0$)

   * For **binary predictor**: ($p_0 = P(Y=1\\mid X=0)$) (event rate in the reference group).
   * For **continuous predictor**: ($p_0$) is typically interpreted as the event rate at the **mean** of ($X$) (after centering).

4. **Target odds ratio** ($\\mathrm{OR}$)
   The smallest OR that is clinically meaningful and worth detecting.

5. **Predictor type**

* **Binary predictor**: requires **prevalence of (X=1)**, denoted ($q=P(X=1)$).
* **Continuous predictor**: typically requires the OR for a **1 SD increase** (or you must convert using SD).

6. **($R^2$) with other covariates**
   ($R^2$) is the squared multiple correlation from regressing ($X$) on other covariates in a multivariable model.

   * If ($X$) is correlated with other predictors, the effective information about ($\\beta_1$) decreases, so the required sample size increases.

---

# Calculation

## Step 1 ‚Äî Convert OR and baseline risk to ($p_1$) (binary ($X$))

If ($X$) is binary, compute the event rate in the exposed group ($p_1=P(Y=1\\mid X=1)$) from ($p_0$) and OR:

$$
\\text{odds}_0=\\frac{p_0}{1-p_0},\\quad \\text{odds}_1=\\mathrm{OR}\\cdot \\text{odds}_0,\\quad
p_1=\\frac{\\text{odds}_1}{1+\\text{odds}_1}
$$

Overall event rate:
$$
p=(1-q)p_0+q p_1
$$

## Step 2 ‚Äî Z-scores

Let:
$$
z_{\\alpha}=z_{1-\\alpha/2}, \\qquad z_{\\beta}=z_{1-\\beta}=z_{\\text{power}}
$$

## A) Binary predictor sample size (Hsieh approach)

With ($q=P(X=1)$), ($p_0=P(Y=1\\mid X=0)$), ($p_1=P(Y=1\\mid X=1)$), and ($p$) as above:

$$
n_0=
\\frac{
\\left[
z_{\\alpha}\\sqrt{\\frac{p(1-p)}{q(1-q)}}
+
z_{\\beta}\\sqrt{\\frac{p_1(1-p_1)}{q}+\\frac{p_0(1-p_0)}{1-q}}
\\right]^2
}
{(p_1-p_0)^2}
$$

### Adjustment for correlation with other covariates

If you plan a multivariable model and the predictor of interest ($X$) correlates with other covariates, inflate the sample size using:

$$
n=\\frac{n_0}{1-R^2}
$$

### Expected number of events

$$
E \\approx n\\cdot p
$$

---

## B) Continuous predictor sample size (Hsieh approach)

Assume a logistic model with a continuous predictor ($X$) and define OR for a **1 SD increase** in ($X$), denoted ($\\mathrm{OR}_{SD}$). Let ($p_0$) be the event rate at the mean of ($X$):

$$
n_0=\\frac{(z_{\\alpha}+z_{\\beta})^2}{p_0(1-p_0) [\\log(\\mathrm{OR}_{SD})]^2}
$$

If the user has an OR per 1-unit increase, ($\\mathrm{OR}_{unit}$), and SD of ($X$) is ($\\sigma_X$), convert:
$$
\\log(\\mathrm{OR}_{SD})=\\log(\\mathrm{OR}_{unit})\\cdot \\sigma_X
$$

Then apply the same multivariable correlation inflation:
$$
n=\\frac{n_0}{1-R^2}
$$

---

## Practical guidance: what values to choose (common conventions)

* **($\\alpha$)**: 0.05 (two-sided) is typical; use smaller ($\\alpha$) if multiple testing is expected.
* **Power**: 0.80 is common; 0.90 is preferred when missing the effect would be costly.
* **OR**: choose the **minimum clinically meaningful** OR (often in the 1.2‚Äì2.0 range depending on context).
* **Baseline risk ($p_0$)**: use local hospital/cohort data if available; otherwise use literature estimates and run sensitivity analyses.
* **Binary predictor prevalence ($q$)**: use local prevalence; note ($q$) near 0.5 gives the **largest information** (smaller ($n$)); very small/large ($q$) increases required ($n$).
* **($R^2$)**: if uncertain, run a sensitivity range (e.g., 0, 0.1, 0.25, 0.5). Even moderate correlation can inflate ($n$) substantially via ($1/(1-R^2)$).
* **Continuous predictors**: consider standardizing ($X$) to mean 0, SD 1 so ($\\mathrm{OR}_{SD}$) is easy to interpret.

---

## Key references (2‚Äì5)

1. Hsieh FY, Bloch DA, Larsen MD. *A simple method of sample size calculation for linear and logistic regression.* Statistics in Medicine. 1998;17(14):1623‚Äì1634.
2. Hsieh FY. *Sample size tables for logistic regression.* Statistics in Medicine. 1989;8(7):795‚Äì802.
3. Whittemore AS. *Sample size for logistic regression with small response probability.* Journal of the American Statistical Association. 1981;76:27‚Äì32.
""",
        "c5_content_md": """
### What this method is

C5 implements the **Riley et al. analytical minimum sample size criteria** for **developing a multivariable clinical prediction model** with a **binary outcome** (logistic regression). The goal is to ensure the development dataset is large enough to:

1. **Limit overfitting** (via a target global shrinkage / calibration slope),
2. Achieve **adequate precision** for model performance (via a bound on optimism in $R^2$), and
3. Estimate the **overall outcome risk** (intercept/baseline risk) with acceptable precision.

This is a **model development** method (not external validation). It is particularly suitable when you plan a **pre-specified model form** (predictors and coding defined in advance) and want a **principled alternative to EPV rules**.

---

### When to use

Use C5 when:

* You are **developing** a new prediction model for a **binary outcome**.
* You can specify (even approximately) the **event rate** and an anticipated **overall model performance** (Cox‚ÄìSnell $R^2$ or AUC).
* You want to target **low overfitting** (e.g., shrinkage $S \\ge 0.90$) and reasonable precision.

### When NOT to use (or use with caution)

Do not rely on C5 alone when:

* You will do extensive **data-driven variable selection**, multiple interactions/splines, or heavy ML tuning without adjusting the **effective number of parameters (df)**.
* Your data are strongly **clustered** (multicenter) without accounting for design effects.
* The intended modeling approach is not standard logistic regression (e.g., complex ML) unless you map complexity to an appropriate **effective df** or switch to simulation-based sizing.
* You cannot justify any plausible performance input (AUC/$R^2$); in that case run wide sensitivity analyses and consider simulation-based methods.

---

## Key inputs (what each means)

1. **Outcome prevalence / event rate** (p)
   Expected proportion with (Y=1) in the development dataset.

2. **Number of predictor parameters (df)** (P)
   Total degrees of freedom for all candidate predictors **excluding the intercept**.
   Include: dummy variables, spline bases, interactions (and any other basis expansions).

3. **Anticipated performance** (choose one)

* **Cox‚ÄìSnell ($R^2_{CS}$)**: preferred if available from related prior studies (ideally optimism-adjusted).
* **AUC (C-statistic)**: if $R^2_{CS}$ is unavailable, the tool can approximate $R^2_{CS}$ from AUC and ($p$) using a published approach.
* **Conservative (15% of max $R^2$)**: a fallback when neither AUC nor $R^2$ is available; use with caution.

4. **Target global shrinkage** (S)
   A target for **overall overfitting control** (often interpreted similarly to an expected calibration slope after internal validation).

* Common default: $S = 0.90$ ($\\approx$ 10% shrinkage of predictor effects).
* More conservative: $S = 0.95$ (requires larger sample size).

---

## Core concepts and formulas

### Cox‚ÄìSnell ($R^2$) and its maximum

Cox‚ÄìSnell ($R^2$) for a fitted logistic model can be written as:
$$
R^2_{CS} = 1-\\exp\\left(\\frac{2}{n}(\\ell_0-\\ell_1)\\right),
$$
where $\\ell_0$ is the intercept-only log-likelihood and $\\ell_1$ is the model log-likelihood.

For binary outcomes, $R^2_{CS}$ cannot reach 1. Its maximum depends on the outcome prevalence:
$$
\\ell_0 = n\\Big[p\\ln(p) + (1-p)\\ln(1-p)\\Big],
$$
$$
R^2_{CS,\\max}=1-\\exp\\left(\\frac{2\\ell_0}{n}\\right)
=1-\\exp\\Big(2[p\\ln(p) + (1-p)\\ln(1-p)]\\Big).
$$

Nagelkerke ($R^2$) rescales Cox‚ÄìSnell ($R^2$) to ([0,1]):
$$
R^2_{Nag}=\\frac{R^2_{CS}}{R^2_{CS,\\max}}.
$$

---

## The three Riley criteria (binary outcome)

### Criterion 1 ‚Äî Control overfitting via target shrinkage (S)

Minimum sample size to target global shrinkage (S):
$$
n_1=\\left\\lceil
\\frac{P}{(S-1)\\ln\\left(1-\\frac{R^2_{CS}}{S}\\right)}
\\right\\rceil.
$$

### Criterion 2 ‚Äî Limit optimism in ($R^2$) (default absolute difference 0.05)

This criterion targets a small absolute difference (default $\\delta=0.05$) between apparent and adjusted **Nagelkerke** ($R^2$). The required shrinkage implied by this constraint is:
$$
S_{\\delta}=\\frac{R^2_{CS}}{R^2_{CS}+\\delta R^2_{CS,\\max}}.
$$
Then:
$$
n_2=\\left\\lceil
\\frac{P}{(S_{\\delta}-1)\\ln\\left(1-\\frac{R^2_{CS}}{S_{\\delta}}\\right)}
\\right\\rceil.
$$

### Criterion 3 ‚Äî Precise estimation of the overall outcome risk (intercept)

This targets precision of the **average outcome risk** ($p$) (baseline risk) within ($\\pm d$) on the probability scale (default $d=0.05$ at 95% CI):
$$
n_3=\\left\\lceil
\\left(\\frac{z_{1-\\alpha/2}}{d}\\right)^2 p(1-p)
\\right\\rceil,
\\quad \\text{default } z_{0.975}=1.96,; d=0.05.
$$

### Final recommendation

$$
n_{\\min}=\\max(n_1,n_2,n_3),\\qquad
E = n_{\\min}p,\\qquad
EPP=\\frac{E}{P}.
$$

---

## Practical guidance (typical choices)

* **Shrinkage (S)**: use **0.90** as a standard target; consider **0.95** if you want stronger overfitting control or if the model is complex.
* **$\\delta=0.05$** for Criterion 2: commonly kept at the default.
* **Intercept precision (d=0.05)**: default corresponds to estimating baseline risk within ¬±5%. If baseline risk must be estimated more precisely, you would need a smaller ($d$) (larger ($n$)).
* **Anticipated ($R^2_{CS}$)**:

  * Prefer **optimism-adjusted** values from related studies (or apparent values from external validation data).
  * If only AUC is available, use the published AUC‚Üí$R^2_{CS}$ approximation method.
  * If neither is available, the **15% of $R^2_{CS,\\max}$** option is a conservative fallback for exploratory planning‚Äîalways run sensitivity analyses.

---

## Key references (2‚Äì5)

1. Riley RD, Snell KIE, Ensor J, et al. *Minimum sample size required for developing a multivariable prediction model: PART II‚Äîbinary and time-to-event outcomes.* Statistics in Medicine. 2019.
2. Riley RD, Ensor J, Snell KIE, et al. *Calculating the sample size required for developing a clinical prediction model.* BMJ. 2020.
3. Riley RD, Van Calster B, Collins GS. *A note on estimating the Cox‚ÄìSnell ($R^2$) from a reported C statistic (AUROC) to inform sample size calculations for developing a prediction model with a binary outcome.* Statistics in Medicine. 2021.
4. Harrell FE Jr, Lee KL, Mark DB. *Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.* Statistics in Medicine. 1996.
""",
    }
}
